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Celiac Disease (CD) is a multisystem disorder that is caused by gluten and affects 
approximately 1% of the United States population.  Approximately 10% of CD patients 
have neurological complications, such as ataxia, brain atrophy, dementia, epileptic 
seizures, peripheral neuropathy, and cognitive impairment.  CD patients have also been 
found to have lower health-related quality of life (HRQL) than the general population.  
Given the established relationships of physical activity and aerobic fitness with HRQL 
and executive function in other chronic disease populations and in older adults, it seems 
likely that these same relationships may exist for CD patients.  However, these 
relationships have not been investigated.  Therefore, the purpose of this study was to 
determine if both physical activity (number of vigorous bouts of physical activity/week; 
MET hours/week) and aerobic fitness were positive predictors of HRQL and executive 
function in CD patients.  The relationship of functional fitness with those same outcome 
variables was also explored given the established positive relationship between functional 
fitness and HRQL.  Separate canonical correlations were used for the HRQL composite 
and the executive function composite with the physical activity measures, aerobic fitness, 
and functional fitness.  Canonical correlations for the HRQL composite with number of 
vigorous bouts of physical activity/week, MET hours/week, aerobic fitness, or functional 
fitness were not statically significant.  However, canonical correlations for the executive 
function composite with number of vigorous bouts of physical activity/week (Rc = .55; 
 
p=0.02) and functional fitness (Rc = .57; p=0.01) were statistically significant.  The 
results do not support positive relationships for any of the predictor variables with 
HRQL, and this may be due to our high functioning CD sample, which scored higher 
than normative scores on measures of HRQL.  However, these findings do support a 
positive relationship for number of vigorous bouts of physical activity/week and 
functional fitness with executive function.  
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PREFACE 
Celiac Disease (CD) is a greatly undiagnosed hereditary autoimmune disorder.  
Four of my immediate family members have CD and the process of diagnosis for many 
of us was enduring.  When I was diagnosed and began researching the topic in 2003, I 
noticed the lack of research addressing mental health and health-related quality of life 
(HRQL) in those with CD, as well as a lack of awareness in the community about the 
disease and the gluten free diet.  I continued reading peer-reviewed articles on many CD 
related topics and while in graduate school developed a passion for studying how 
physical activity was related to HRQL and executive function.  Further readings of 
research on medical pathologies and neurology in CD patients, encouraged me to develop 
hypotheses about what was occurring with HRQL and executive function in CD patients.  
There was no research exploring the potential benefits of physical activity, a behavior 
that has been linked to positive mental and physical health in adult populations, older 
adults, and many chronic disease populations.  Therefore, this current research was 
developed to fill a gap in both the CD and physical activity literature, while also 
supporting areas of research that I am truly committed to. 
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CHAPTER I 
INTRODUCTION 
 
 
Celiac Disease (CD) is a multisystem disorder that is caused by gluten and affects 
approximately 1% of the United States population (Dubé et al., 2005).  CD is greatly 
underdiagnosed and is the most common hereditary autoimmune disorder in the U.S. 
(Green & Jones, 2006).  In samples with CD that responded to surveys or when biopsy 
CD disease patients were assessed, two to three times as many adult women as adult men 
were found to have CD (Green, 2005; Green et al., 2001).  CD is associated with 
neurological complications, such as ataxia, brain atrophy, dementia, epileptic seizures, 
and peripheral neuropathy (Green & Jones, 2006; Hu, Murray, Greenaway, Parisi, & 
Josephs, 2006; Kieslich et al., 2001; Vaknin, Eliakim, Ackerman, & Steiner, 2004) and 
cognitive impairment (Burk et al., 2001).  Further, there is an association with increased 
depression (Addolorato et al., 2001), anxiety (Addolorato et al., 2001), and fatigue 
(Siniscalchi et al., 2005).  Low levels of quality of life (QoL) (Hallert et al., 2002; Hallert 
et al., 1998) and low levels of health-related quality of life (Häuser, Gold, Caspary, & 
Stallmach, 2006; Häuser, Stallmach, Caspary, & Stein, 2007) have also been associated 
with CD. 
 QoL, health related quality of life (HRQL), and cognition, specifically executive 
function, are particularly important outcome variables to target when treating CD 
patients.  CD patients have been found to have lower HRQL than the general population 
(Häuser et al., 2006) yet HRQL is an important consideration for CD patients due to their 
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need for lifelong adherence to the gluten-free (GF) diet and the complications of having a 
chronic disease.  In fact, the National Institute of Health now mandates that any study 
that assesses gastrointestinal (GI) disease, such as CD, must also assess HRQL.   
 In addition to hampered HRQL, approximately 10% of CD patients have 
neurological complications (Addolorato et al., 2004; Ghezzi & Zaffaroni, 2001; Holmes, 
1997) which occur in both child and adult onset CD.  Neurological symptoms include 
neuropathy (Kaplan et al., 1988), ataxia (Cooke & Smith, 1966), brain atrophy (Hu, 
Murray, Greenaway, Parisi, & Josephs, 2006), epilepsy (Holmes, 1997), and dementia 
(Hu et al., 2006).  Further, CD patients have been found to have neurological deficiencies 
in brain regions associated with executive functioning.  Deterioration of the cerebellum, 
brainstem, spinal cord, and deep gray matter (Beyenburg, Scheid, Deckert-Schluter, & 
Lagreze, 1998; Kinney, Burger, Hurwitz, Hijmans, & Grant, 1982) has been found in CD 
patients, along with lesions within the white matter of the brainstem, cerebellum, and 
cerebrum (Ghezzi, Filippi, Falini, & Zaffaroni, 1997).  Focal, diffused, or nonspecific 
frontal lobe changes and dense basal ganglia calcifications have also been found in CD 
patients (Hu et al., 2006).  Finally, lower cerebral perfusion in the frontal and parietal 
lobes has been found in CD patients (Addolorato et al., 2004).   
Although there have been numerous studies conducted on the physiology of these 
neurological complications using magnetic resonance imaging, research investigating 
cognitive performance and behavioral implications as a result of these neurological 
deficiencies in CD patients is limited.  In fact, there are only three articles to date that 
have employed cognitive performance tests.  Hallert and Astrom (1983) demonstrated no 
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cognitive impairment in adult CD patients when neurological test scores were compared 
to those of the general population.  However, Burk et al. (2001) found significant 
differences in executive function in those with cerebral ataxia who also had gluten 
sensitivity compared to healthy controls.  Hu et al. (2006) showed global cognitive 
impairment, memory deficits, and learning inefficiency in five CD patients compared to 
normative data.  The mixed findings and the extremely limited cognitive behavioral 
research in CD patients suggest that further research is warranted. 
Currently, most of the CD-related QoL/HRQL and neurological research has 
focused on the impact of the gluten free (GF) diet.  The results have been mixed in that 
some research has found that CD patients currently adhering to the GF diet were not 
different, in terms of reported QoL, from healthy controls (Viljamaa et al., 2005); 
however, other research has found that the GF diet is at times able to improve HRQL, but 
not to the level of the general population (Häuser et al., 2006).  Further, the GF diet has 
not been found to impact the progression of neurological complications.  Therefore, 
knowing that the GF diet may not be able to normalize HRQL in CD patients, or affect 
the progression of neurological diseases, other behavioral approaches that have been 
shown to impact HRQL and cognition should be investigated in CD populations.  
Specifically, the potential influence of physical activity and aerobic fitness on HRQL and 
cognitive performance in CD patients should be explored.   
There are established relationships between physical activity and QoL in older 
adults (Courneya & Friedenreich, 1999; Rejeski & Mihalko, 2001) and chronic disease 
populations (Courneya & Friedenreich, 1999; Katula, Blissmer, & McAuley, 1999; 
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Mannerkorpi, Nyberg, Ahlmen, & Ekdahl, 2000).  Further, there are numerous studies 
that assess the impact of physical activity in other populations and these studies have 
been meta-analytically reviewed for elderly persons with cognitive impairment (Heyn, 
Abreu, & Ottenbacher, 2004), healthy and sedentary older adults (Colcombe et al., 2003), 
children (Sibley & Etnier, 2003) and across all ages (Etnier, Nowell, Landers, & Sibley, 
2006; Etnier et al., 1997). These meta-analyses consistently show that chronic physical 
activity positively impacts cognitive performance.   
Despite the large body of literature demonstrating positive relationships between 
chronic physical activity and psychological outcomes in healthy populations and in a 
variety of chronic illnesses, these relationships between physical activity and HRQL in 
people with CD have only been explored once in a preliminary pilot.  HRQL and 
satisfaction with life (SWL) were investigated in CD patients as part of a preliminary 
study, which was split into 2 phases.  In Phase 1, there was a statistically significant 
correlation (r=.70) between bouts of vigorous physical activity and the HRQL composite.  
In Phase 2, moderate positive correlations were found for VO2 peak with the SF-36 
aggregate physical component score.  MET hours per week did not strongly predict 
HRQL or SWL in either phase.  The findings from Phase 1 are encouraging and 
additional survey research is needed to clarify the relationships found and further explore 
the measures of physical activity.  The small sample in Phase 2 does not allow strong 
conclusions to be drawn, but does provide us with exploratory evidence of the 
relationships between VO2 peak and HRQL.     
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This pilot study data illustrates the need to determine if physical activity and 
aerobic fitness are related to HRQL and cognitive performance in daily life for CD 
patients.  First, correlational studies will be needed to determine if a relationship exists 
and the strength of that relationship.  Once this is determined, causal studies can be 
developed to determine the effect of physical activity and the optimal dose.  Physical 
activity has not been explored as a potential behavioral treatment in CD patients, yet 
based upon past research with other populations, physical activity clearly has the 
potential to improve both HRQL and cognitive performance.  This gap in the literature 
has led me to propose assessing both HRQL and executive function in CD patients 
through a correlational design, as it is critical to find a behavioral tool, such as physical 
activity, that might be beneficial for these impaired areas in CD patients.  
Therefore, the overall objective of this research is to identify the degree to which 
physical activity and aerobic fitness predict HRQL and cognitive function in CD patients.  
The primary hypothesis is that both higher self-reported physical activity and higher 
aerobic fitness will significantly predict higher HRQL in CD patients.  The secondary 
goal is to determine the relationship between physical activity, aerobic fitness and 
cognitive function in CD patients.  I hypothesize that both higher self-reported physical 
activity and higher aerobic fitness will significantly predict better cognitive function in 
CD patients.  Finally, the relationship between functional fitness, executive function, and 
HRQL will also be investigated on an exploratory basis. 
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The specific aims are as follows: 
Specific Aim #1 is to identify the degree to which self-reported physical activity 
(MET hours per week; number of bouts of vigorous physical activity) and aerobic fitness 
predict HRQL in CD patients. 
Specific Aim #2 is to identify the degree to which self-reported physical activity 
(MET hours per week; number of bouts of vigorous physical activity) and aerobic fitness 
predict executive function in CD patients. 
The exploratory aim is designed to investigate the relationship between functional 
fitness, as measured by the Timed Up and Go Test (TUG), and HRQL and executive 
function in CD patients. 
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CHAPTER II 
 
REVIEW OF THE LITERATURE 
 
 
Introduction 
 
It is believed that Celiac Disease (CD) affects 1% of the U.S. population and it is 
estimated that 97% of these people are currently undiagnosed (Green & Jones, 2006).  In 
CD research, two to three times as many adult women have CD as adult men; however, 
after 65 years of age, the number of women with CD is more similar to the number of 
men with CD (Green et al., 2001).  Not only is CD greatly underdiagnosed, but the 
average time to diagnosis is approximately 9 years (Green & Jones, 2006).  Further, it is 
now recognized as the most common hereditary autoimmune disease in the U.S. (Green 
& Jones, 2006).  Neurological complications (Hu et al., 2006; Kieslich et al., 2001; 
Vaknin et al., 2004) have been found to be associated with CD.  Further, increased 
depression (Addolorato et al., 2001), anxiety (Addolorato et al., 2001), and heightened 
fatigue (Siniscalchi et al., 2005) have been found in those with CD.  Low levels of quality 
of life (Hallert et al., 2002; Hallert et al., 1998), and low levels of health related quality of 
life (Häuser et al., 2006; Häuser et al., 2007) are also present in some CD patients.   
In fact, at the NIH Consensus Statement on CD (2004), it was stated that 
researchers should “investigate the quality of life in individuals with CD”.  The term 
quality of life (QoL) encompasses many aspects of one’s overall well-being, including 
mental, physical, social, and cognitive aspects.  Further, maintaining cognitive abilities 
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throughout one’s lifetime is important as cognitive performance has implications for 
individuals in the workforce, relationships, and overall QoL. 
Physical activity is a behavior that may be important for psychological health, 
QoL, and cognitive performance.  There are established relationships between physical 
activity and health-related quality of life (HRQL) or QoL in older adults (Courneya & 
Friedenreich, 1999; Rejeski & Mihalko, 2001) and chronic disease populations 
(Courneya & Friedenreich, 1999; Katula, Rejeski, Wickley, & Berry, 2004; Mannerkorpi 
et al., 2000).  Physical activity consistently has been shown to have a positive influence 
on QoL in older adults (Elavsky et al., 2005).  In other populations, acute exercise 
(Brisswalter, Arcelin, Audiffren, & Delignieres, 1997; Etnier et al., 1997; Tomporowski, 
2003) and chronic exercise (Colcombe & Kramer, 2003; Etnier et al., 1997) have been 
shown to positively impact cognitive performance; however, this relationship has not 
been tested in CD patients.   
Given the research indications that higher physical activity levels are associated 
with improved HRQL and cognitive functioning in the general population and in certain 
disease populations, it seems plausible that physical activity, and possibly aerobic fitness, 
may be positively associated with HRQL and cognitive performance in CD patients.  
These questions have not been addressed with CD patients. 
Celiac Disease 
Overview 
CD is a multi-symptom disorder that is caused by gluten sensitivity, which affects 
approximately 1% of the United States population (Dubé et al., 2005).  In a survey 
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administered to CD support groups in the United States more women than men responded 
to having CD (2.9:1); however, in those over 65 years of age, the number of females is 
more similar to the number of males (Green et al., 2001).  Also, when biopsy diagnosed 
CD patients were assessed at the Celiac Center at Columbia University, the ratio of 
women to men was 1.7 to 1.0 (Green, 2005)   In the Italian population, the percentage of 
female study participants with CD was slightly higher than the percentage of male study 
participants (52.1% vs. 47.9%) (Volta et al., 2001).   
CD was originally called Celiac Sprue.  In people with CD, the attempt to digest 
gluten, the major protein component of wheat, triggers an immune response.  Immune 
responses cause inflammation and villous atrophy (flattening or shrinking of the villi) in 
the small intestine.  As a result of this inflammation and flattening of the villi, negative 
symptoms begin to occur.  These symptoms of CD include malabsorption, dental enamel 
defects, fatty stools, amenorrhea and delayed puberty, diarrhea, distended stomach, 
vomiting, fatigue, and failure to thrive (in some CD patients) (Alaedini & Green, 2005).  
If GI symptoms are lacking, then CD patients are classified as having “asymptomatic”, 
“atypical” or “silent” CD (Green & Jabri, 2006).  Additional complications include 
insulin-dependent diabetes mellitus, lymphoma, iron-deficiency anemia, thyroid disease 
(Carta et al., 2002) and osteoporosis (Green & Jabri, 2006). For example, insulin 
dependent diabetes mellitus in CD patients has been reported to be 8-10% (Green & 
Jabri, 2006), where the prevalence in non-CD patients is 7.8% (National Institute of 
Diabetes and Digestive and Kidney Diseases, 2008).  Other autoimmune diseases have 
been found to occur three to ten times more often in CD patients than in the general 
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population (Green & Jabri, 2006).  There is no cure for CD and the only treatment 
available is compliance with the gluten free (GF) diet.  The GF diet consists of 
elimination of wheat, rye and barley (Green & Cellier, 2007).  
Gluten Free Diet 
 Currently the GF diet is the only therapy and treatment for patients with CD.  
Non-diet therapies, such as recombinant enzymes that digest the gliadin fractions (a 
component of gluten), are being investigated (Green & Cellier, 2007); however, their 
effectiveness has yet to be determined.  Instead, it appears that elimination of gluten, 
which is found in wheat, barley and rye, is critical.  The GF diet is the only therapy that is 
known to alleviate malabsorption and lower the risks of complications, specifically 
intestinal lymphoma (Ciacci, Iavarone, Mazzacca, & De Rosa, 1998).  Non-compliance 
with the GF diet can lead to both mental and physical ailments, such as lower QoL, 
refractory sprue and lymphoma (Green & Cellier, 2007). 
 Non-compliance with the GF diet has been investigated in nation-wide surveys.  
A national (United States) survey was conducted on 1612 CD patients and found only 
68% of the sample to be compliant with the GF diet “all of the time” and 30% to be 
compliant “most of the time” (Green et al., 2001).  
 In addition to diet compliance, diet nutrition is being investigated.  The GF diet 
substitutes many grains (wheat, barely, rye) with non-gluten grains and ingredients (rice, 
tapioca, potato starch).  These substitute flours are usually not fortified with B vitamins 
(Green & Cellier, 2007) and sole reliance on them might lead to vitamin deficiencies.  
These findings are interesting given the potential role of vitamins B6 (Kado et al., 2005), 
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B12 (Morris et al., 2005) and folic acid (Feng, Ng, Chuah, Niti, & Kua, 2006; Kado et al., 
2005; Mischoulon & Raab, 2007) in cognitive function.  Green and Cellier (2007) 
recommend assessment of vitamins and mineral deficiencies after initiation of the GF 
diet.  These assessments include folic acid, fat soluble vitamins, calcium, iron, and B12.   
The research is conflicting about the improvement or alleviation of symptoms 
associated with CD.  For example, Murray et al. (2004) found improvements in diarrhea 
and weight loss upon introduction of the GF diet.  Yet, Midhagen and Hallert (2003) 
found that 8-12 years on the GF diet did not influence GI symptoms, as the CD patients 
still had a higher incidence of GI symptoms than the general population.  So, it may be 
the case that GI symptoms improve in CD patients on the GF diet, yet the CD patients 
will never be equal in symptomology to the general population.   
Compliance with the GF diet might increase HRQL in some, since the symptoms 
have lessened; however, the GF diet may also decrease HRQL in others, due to the social 
implications and demands of adhering to the diet.  Further, there are many conflicting 
scholarly opinions on how the GF diet impacts HRQL (these will be discussed later).   
 In addition to the GF diet’s impact on HRQL, investigators have also studied its 
impact on neurological complications.  However, in most cases, neurological symptoms 
have rarely been found to respond to the GF diet.   
Celiac Disease and Neurology 
Overview 
Neurological symptoms in CD patients have been reported anecdotally, through 
case studies, and through the use of cross-sectional and retrospective designs.  
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Neurological symptoms include neuropathy (Kaplan et al., 1988), ataxia (Cooke & 
Smith, 1966), brain atrophy (Hu et al., 2006), epilepsy (Holmes, 1997), and dementia (Hu 
et al., 2006).  These neurological symptoms occur in about 10% of CD patients 
(Addolorato et al., 2004; Ghezzi & Zaffaroni, 2001; Holmes, 1997) and can occur in both 
child and adult onset CD.  The prevalence of epilepsy in CD patients has been reported to 
be between 3.5% - 5.5% (Chapman, Laidlow, Colin-Jones, Eade, & Smith, 1978; 
Holmes, 1997).  Chapman et al. (1978) found that 5% of the CD patients developed 
epilepsy, while Holmes (1997) found epilepsy in 3.6% of the 388 CD patients that he 
examined retrospectively.  Further, the presence of migraine or tension headaches in CD 
patients is 46% (Cicarelli et al., 2003). Finally, Cook and Smith (1966) found sensory 
ataxia in all 16 of their CD patients.   
Research 
Much of the early research on CD and neurology used anecdotal and 
single/multiple case study methods to investigate neurological symptoms in CD patients; 
however, recent research on the neurological complications associated with CD has used 
both cross-sectional and retrospective designs, to assess the presence of neurological 
complications in CD patients.   
In most cases, neurological symptoms have rarely been found to respond to the 
GF diet.  However, patients with epilepsy and cerebral calcifications have responded 
slightly to the diet, in that the course of the epilepsy improves with quick initiation of the 
GF diet upon onset of epileptic seizures, but the disease is not completely cured (Ghezzi 
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& Zaffaroni, 2001).  Further, Collin et al. (1991) found that one patient in their sample of 
five, with CD, brain atrophy and dementia, responded to the GF diet.   
Cooke and Smith’s (1966) classic study on malabsorption and CD, which used a 
case study design, showed that CD patients (11 men; 5 women) did not respond to gluten 
restriction and upon biopsy showed osteomalacia (5 patients), atrophy and focal loss of 
neurons (6 patients), purkinje cell loss (5 patients), and spinal cord degeneration (4 
patients), spongiform demyelination, and lymphocytic infiltration. 
Vaknin et al. (2004) retrospectively evaluated the severity and prevalence of 
neurological disorders associated with CD.  Over the 20 years examined, 148 patients 
were diagnosed with CD and the neurological abnormalities were listed based on patient 
charts and then divided into two categories.  Twenty-one neurological disorders that 
could not be attributed to any other condition but CD presented themselves in 12% of the 
patients (n=18).  CD diagnosis preceded the neurological abnormalities in 15 of the 18 
cases.  Neurological disorders that were probably unrelated to CD (n=8) were found in 
5.5% of the CD sample.  The exact mechanism for these disturbances is not known; 
however, malabsorption of nutrients, absorption of toxic substances, deficiency states, 
metabolic abnormalities, or immune-mediated mechanisms are potential mechanisms 
(Vaknin et al., 2004).  
Zelnik, Pacht, Obeid, and Lerner (2004) conducted a study to investigate the 
association between more common or “soft” neurological concerns and CD in 
adolescents and children (n=111) and an age- and gender-matched control group (n=211).  
CD patients were more likely to develop neurological disorders, hypotonia, 
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developmental delay, learning disorders, attention deficit hyperactivity disorder (ADHD), 
headache, and cerebellar ataxia, when compared to the control subjects (51.4% vs. 
19.9%) (Zelnik et al., 2004).  The GF diet only benefited those with infantile hypotonia 
and migraines or non-specific headache.   
Kieslich et al. (2001) found neurological abnormalities in 10 of 75 pediatric CD 
patients and white-matter lesions in 20% of the 75 pediatric CD patients.  All patients 
were on the GF diet for approximately 2.4 years and the white-matter lesions were not 
related to GF diet compliance or GI symptoms (Kieslich et al., 2001).   
Addolorato et al. (2001) investigated brain perfusion changes, using cerebral 
single photon emission computed tomography examination, in 15 CD patients not on the 
GF diet, 15 CD patients on the GF diet for 1-year, and 24 healthy controls.  The CD 
patients not on the GF diet had significantly lower cerebral perfusion in the frontal and 
parietal lobes than the healthy controls (11 of the 15 CD non-GF diet patients had one 
hypoperfused brain area vs. 0 of the 25 controls).  There were no differences between the 
CD GF diet patients and the controls (1 of the 15 GF diet patients had one hypoperfused 
brain area vs. 0 of the 25 controls).   
Carta et al. (2002) investigated the role of thyroid disorders, anxiety disorders, 
and depressive disorders in 36 CD patients and 144 healthy sex- and age-matched 
controls since thyroid disease is present in CD patients and hypothyroidism may be an 
additional risk factor for psychiatric disorders.  Using psychiatric evaluations, guided by 
the DSM-IV criteria and thyroid evaluations, they found that CD patients had higher 
lifetime and 6-month major depressive disorder and panic disorder than the control 
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group.  Symptoms of CD were reported at an earlier age (12.8 years vs. 21.5 years) in CD 
patients with major depressive disorder than CD patients without major depressive 
disorder.  When thyroid disease was assessed, Carta et al. found a higher prevalence of 
anti-thyroid autoantibodies in CD patients than in the control group (30.5% vs. 9.7%).  
Most interesting was the association between panic disorder, major depressive disorder, 
and anti-thyroid antibodies, in that there was a higher frequency of panic disorder and 
major depressive disorder found in CD patients with positive anti-thyroid autoantibodies.  
The association between CD, hypothyroidism, and depression provides support for 
thyroid disease being a potential mechanism of depression in CD patients.  Possible 
explanations for this mechanism include the effect of the symptoms of both 
hypothyroidism and CD on energy levels (fatigue) and therefore, one’s ability to sustain 
activity and a high level of QoL.   
Proposed Mechanisms 
In addition to the thyroid mechanisms mentioned above and the potential 
mechanisms listed by Vaknin et al. (2004), there are some other hypotheses that have 
been used to explain the presence of neurological manifestations in CD patients.   
First, nutritional issues, such as vitamin malabsorption, B-12 deficiency, and folic 
acid deficiency, may be involved in central nervous system (CNS) functioning.  The data 
supporting these hypotheses are mixed and inconclusive; however in some studies, folate 
has been found to be associated with depression (Bjelland, Ueland, & Vollset, 2003; 
Bottiglieri, 2005; Carney, 1967; Tiemeier et al., 2002) and neurodegenerative disorders 
(Hu et al., 2006).  Also, Kupper (2005) reviewed studies that addressed CD and the GF 
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diet and found that lesion pronouncement in the small intestine was negatively related to 
vitamin (folate, B12) and mineral (iron, cooper) levels.  Also, correlations have been 
found between zinc deficiency and the severity of the villi atrophy (Kupper, 2005). 
Second, the presence of antigliadin antibodies, as noted in Hadjivassiliou et al. 
(1996), may be associated with neurological deficiencies in CD patients.  Antigliadin 
antibodies, which can be measured by a serologic test, are positive in the presence of 
gluten.  Therefore, inflammation, tissue damage, and villous atrophy have probably 
occurred.  The presence of these symptoms, and thus expansion of the B cells to produce 
antibodies could be linked to neurological deficiencies, especially those due to 
malabsorption of vitamins and minerals.   
Third, the metabolism of biogenic amines in the CNS may play a role in mental 
illness in CD patients.  The monoamine hypothesis is the most supported hypothesis in 
the CD literature.  Monoamines include catecholamines and serotonin which are 
synthesized from tyrosine and tryptophan, respectively.  This hypothesis has been tested 
by examining the ratio of tyrosine to the sum of large neutral amino acids and the ratio of 
tryptophan to the sum of the remaining large amino acids.  A lower plasma tyrosine or 
tryptophan ratio could be indicative of lower availability of these amino acids to the 
brain.  Hernanz and Palaneo (1991) conducted this analysis in 27 CD children, with 15 of 
them not on the GF diet, and 12 of them on the GF diet, and 12 control subjects.  
Compared to the control group, CD children, adhering and not adhering to the GF diet 
had significantly lower plasma tryptophan ratios.  Also, the non-GF diet CD children had 
significantly lower plasma tryptophan ratios than the GF diet CD children.  The authors 
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suggested that the lowered tryptophan ratio may be suggestive of decreased serotonin 
levels (Hernanz & Polanco, 1991).  Reduced availability of serotonin to the brain may be 
related to depression, mood, and behavioral disturbances. 
Fourth, CD patients who are not on the GF diet have been found to have low 
levels of Crithidia fasciculate, a growth factor for biopterin compounds.  A reduction in 
these biopterin compounds, which act as co-factors for the synthesis of dopamine, 
norepinephrine, epinephrine, tyrosine, and tryptophan, may result in low levels of these 
important amino acids and neurotransmitters (Cooke, 1978).  
Celiac Disease and Cognitive Performance 
Overview and Research 
Although there have been numerous studies conducted on the physiology of these 
neurological complications, research investigating cognitive performance and behavioral 
implications as a result of these neurological deficiencies has been rare.  In fact, only 
three articles have been identified that employed cognitive performance tests.  One study 
was designed to solely assess cognitive behaviors (Hallert & Astrom, 1983) while 
another research study incorporated neuropsychological tests as a means, among others, 
to describe sporadic cerebellar ataxia with gluten sensitivity (Burk et al., 2001).  
Hallert and Astrom (1983) assessed the intellectual ability of 19 untreated 
Swedish CD adults, with a mean age of 48 years.  The test battery, consisted of The 
Synonyms Reasoning Block (SRB) test (includes Koh’s Block design test), Thurston’s 
memory test, reaction time with simple stimulation and 3-choice stimulation, figure 
identification, finger dexterity, figure rotation, design, street, organic integrity test (OIT) 
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and Benton’s visual retention test.  The results showed no cognitive impairment in adult 
CD based on scores of the CD patients on the neurological tests compared to scores of 
general population samples.  Interpretation of these results is difficult for a couple of 
reasons.  Although the CD patients were not behaviorally impaired, it is important to 
remember that neurological complications could still be present, since it has been 
reported that approximately 10% of CD patients experience neurological complications 
(Addolorato et al., 2001; Ghezzi & Zaffaroni, 2001; Holmes, 1997).  In addition, the 
cognitive tests that were used did not focus on measures of executive functioning, thus 
the test battery was not inclusive of all potentially impacted measures of cognition.  
Lastly, even though the tests are supposed to be sensitive to cognitive impairments, only 
subtle impairments were present.  Therefore, the combination of small sample size, a 
failure to include primary measures of executive function, and small cognitive deficits 
could have resulted in nonsignificant findings. 
Burk et al. (2001) investigated sporadic cerebellar ataxia that was associated with 
gluten sensitivity (screened for antigliadin and antiendomysium antibodies) in 104 
patients with ataxia.  Twelve of the 104 had gluten sensitivity.  Neuropsychological 
features were also described in eight of the 12 patients that had positive antibodies and 
nine control subjects after a series of tests were administered.  The tests included the Mini 
Mental State Exam, Verbal IQ, Performance IQ, Digit Span Forward, Digit Span 
Backward, Wechsler Memory Scale (immediate and delayed recall), Word Lists 
(immediate and delayed recall of consecutive, randomized, and uncategorized lists), Rey-
Osterrieth complex figure, Verbal fluency, and the Wisconsin Card Sorting Task.  
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Cognitive tests that are applicable to the current study’s design and/or those which 
showed significant differences between the ataxia patients with gluten sensitivity and the 
controls are presented in Table 1. 
 
Table 1   
Means and Standard Deviations for Relevant and Significant Neuropsychological Tests  
 
 
Cognitive tests 
a
 
Control (N=9) 
M (SD) 
Patient (N=8) 
M (SD) 
 
MMSE  
 
29.6 (0.7) 
 
29.4 (1.1) 
Digit Span (backwards)
 
 5.1 (1.5)` 5.0 (1.2) 
Wisconsin Card Sorting Test – Categories  5.9 (0.3) 3.7 (2.4)* 
Verbal Fluency – phonemic category  12.2 (2.9) 8.5 (2.1)** 
Verbal Fluency – alternating semantic category  15.2 (2.8) 12.4 (2.3)* 
Word Lists – consecutive categories list  9.8 (2.8) 5.9 (1.5)***,+ 
Word Lists – uncategorized list  7.0 (1.6) 3.5 (2.0)***,+ 
Wechsler Memory Scale – immediate recall  12.8 (2.6) 7.8 (2.5)***,+ 
Wechsler Memory Scale – delayed recall  10.3 (2.6) 6.5 (2.5)** 
Note. *p< 0.05, **p<0.01, ***p<0.005 compared to controls; +Bonferroni-Holm adjusted 
p values; 
a 
= higher score is better performance on all tests; Table data from Burk et al. 
(2001) 
 
 
Finally, Hu et al. (2006), retrospectively examined the Mayo Clinic data, between 
1970 and 2005, and reported cognitive test results for five of their 13 CD patients.  
Thirteen biopsy diagnosed CD patients (5 women; 8 men) who experienced progressive 
cognitive decline within two years of their CD diagnosis were examined.  The mean age 
of cognitive impairment was 64 years.  The most common cognitive complaint was 
amnesia (n=12) and the most common symptom was gait ataxia (n = 10).  The Short Test 
of Mental Status was obtained for nine patients and the average score was a 28 (total 38; 
range 18-34).  Five of the 13 patients had neuropsychological test results.  Scores from 
the learning, memory, processing speed, and intellectual intelligence tests indicated that 
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two patients had global cognitive impairment, one patient had memory deficits, and two 
patients had learning inefficiency (Hu et al., 2006).  An EEG was obtained for nine of the 
13 CD patients and eight of the nine CD patients showed different patterns of EEG 
activity than were observed in healthy normal EEGs.  MRIs were performed on seven CD 
patients and six CD patients had generalized atrophy and one had frontal atrophy.  Five 
CD patients had computerized tomography of the head and generalized atrophy was 
found in four and dense basal ganglia calcifications were found in one.  Nutritional 
deficiencies were assessed in six patients, with two having B12 deficiencies and three 
having folate deficiency.  Upon supplementation, cognition was not improved.  At 
follow-up, 10 patients had cognitive deterioration, with nine of the 10 dying from 
progressive dementia (Hu et al., 2006).  The GF diet was only effective in helping three 
of the 13 CD patients, who had stabilization, but not improvements, in their cognitive 
function.  
Future Directions in Celiac Disease, Neurology and Cognitive Research  
 
According to the literature that has assessed the neurology of CD patients, brain 
atrophy, deterioration of the cerebellum, brainstem nuclei, spinal cord, and deep gray 
masses (Kinney et al., 1982) have been found, along with lesions within the white matter 
of the brainstem, cerebellum, and cerebrum (Ghezzi et al., 1997).  Focal, diffused, or 
nonspecific frontal lobe changes, generalized atrophy, and dense basal ganglia 
calcifications have been also found in CD patients (Hu et al., 2006).  Further, lower 
cerebral perfusion in the frontal and parietal lobes were found in CD patients (Addolorato 
et al., 2004).   
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Knowing that these brain areas are affected, specifically the frontal and parietal 
lobes, encourages future research to use cognitive testing to assess executive functions 
specifically associated with those regions.  Executive functions are hampered when 
frontal lobe damage occurs or there is injury to the prefrontal regions.  White matter 
lesions have been associated with reduced processing speed, memory and executive 
functions (Gunning-Dixon & Raz, 2003).  Further, fluid intelligence, an executive 
function, was found to be associated with white matter lesions (Leaper et al., 2001).  
Multiple Sclerosis patients with brain atrophy showed lower scores on executive function 
tests, PASAT, Digit Span Backwards, and short-term memory (Morgen et al., 2005).  
Further, low cognitive performance on the Stroop and word fluency was found in men 
with frontal cortical atrophy (Soderlund, Nyberg, & Nilsson, 2004).  Although there has 
been research on executive function in other populations, the CD population has rarely 
been studied.  Due to the lack of research in this area with CD patients, more 
investigations must be conducted to see if the neurological complications that have been 
described in the literature are affecting cognitive behaviors.  This gap in the literature has 
led me to propose assessing cognitive function in CD patients, specifically executive 
functions that have been shown to be linked to frontal and parietal lobe changes. 
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Celiac Disease and Health-Related Quality of Life 
Overview 
QoL and HRQL have been measured in healthy adults, older adults, and chronic 
disease patients.  These terms are sometimes used interchangeably, with the term, 
“quality of life” being replaced by HRQL or health status in many of the medical 
research studies.  Well-being has also been used, specifically by the World Health 
Organization (WHO), as a component in the definition of health.  The WHO defines 
health as “a state of complete physical, mental, and social well-being and not merely an 
absence of disease or infirmity”(World Health Organization, 1946).  Both the psychology 
literature and exercise literature have defined QoL.  In the psychology literature, QoL has 
been defined by Pavot and Diener (1993) as satisfaction with life that is determined by a 
“conscious cognitive judgment”, while in the exercise literature, QoL has been defined as 
evaluations, both subjective and objective, of both the “goodness” of one’s overall life 
and the domains that are present in one’s life (Lox, Martin Ginis, & Petruzzello, 2006).  
HRQL focuses specifically on QoL areas that can be affected by health interventions.  
Examples include physical function, emotional well-being, and social roles (Lox et al., 
2006).  Finally, HRQL is more than just an objective measure of health – it is the 
individuals’ perception of his/her health and how health or specific health variables 
impact functioning and overall life.   
HRQL is an important consideration for CD patients due to their need for lifelong 
adherence to the GF diet and the complications of having a chronic disease.  HRQL is 
becoming recognized as an important primary or secondary assessment in 
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gastroenterology studies.  The NIH now mandates that any study that assesses GI disease 
must also assess HRQL. 
Most research on HRQL and CD has been designed to assess whether or not 
adherence to the GF diet is associated with differences in important HRQL outcomes.  
Similar to the impact of the GF diet on depression, the research has investigated the 
impact of the GF diet on HRQL and has found mixed results.  In these research studies, 
HRQL has been assessed either with a survey created by the investigators and/or the SF-
36.  Recently, the Celiac Disease Questionnaire (CDQ) (Hauser, Gold, Stallmach, 
Caspary, & Stein, 2007) was created and validated and is now being used solely or in 
conjunction with the SF-36 in research dated post-2006.  In reviewing the extant 
literature, both QoL and HRQL have been examined in CD using a variety of measures. 
Research 
Most research has found that HRQL is impaired in CD patients; however, others 
(Viljamaa et al., 2005) have found no differences between the CD patients and controls 
on HRQL or anxiety/depression measures (Roos, Karner, & Hallert, 2006).  For example, 
Viljamaa et al. investigated screen-detected CD patients who had adhered (94.5% 
adherence rate) to the GF diet for 14 years.  Fifty-three screen detected CD patients were 
compared to one of three control groups (symptom detected CD patients, untreated CD 
patients (not on GF diet) and non-Celiac patients).  Screen-detected CD patients were 
obtained and diagnosed with CD by screening at-risk groups, while symptom-detected 
CD patients were diagnosed after complaining of GI issues.  HRQL was assessed with 
the SF-36 and no difference was found in levels of HRQL between the screen-detected 
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CD patients and the two control groups (symptom-detected CD patients, and non-Celiac).  
Those CD patients who did not adhere to the GF diet had lower HRQL and more GI 
symptoms than the CD patients in the other groups.   
Ciacci et al. (2003) used a cross-sectional design to evaluate self-perceived QoL 
in 581 CD patients (410 women).  Ciacci et al. (2003) contacted 745 CD patients who 
were currently on a GF diet.  Of those contacted, 581 agreed to participate (78% response 
rate; average of 8.26 years on the GF diet).  The questionnaire assessed the CD patients’ 
level of knowledge about the disease, diet compliance, depression, anxiety, and positive 
attitudes.  Diet adherence was high, in that 74.1% of the CD patients had full GF diet 
compliance.  Feelings of overall well-being were assessed on a 4-point scale, with very 
well, well, “so,so”, and bad being the available selections.  Forty-seven percent of the CD 
patients reported that they felt “very well”.  Most interesting were the somewhat 
contradictory differences reported for depression/anxiety and happiness.  That is, 56.6% 
and 74.3% of the CD patients reported that they “rarely” feel anxious or depressed, yet 
45.6% of the CD patients reported that they were not happy (Ciacci et al., 2003).  
Difficulties in social interactions may explain some of the unhappiness (Ciacci et al., 
2003), since 25.6% of CD patients expressed “feeling uneasy at the eating table on 
“several occasions”, while 10.4% and 6.2% of CD patients reported feeling uneasy and 
feeling different “often”.  Two weakness of this study include the lack of a healthy 
control group and the reluctance to explain the variability in responses to the 
depression/anxiety and happiness questions.  One would think that a lack of depression or 
anxiety equates to happiness, but this study did not show that.  Further, it may be that 
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other QoL variables, other than the variables examined in this study, could shed light on 
what determines “happiness” in CD patients.  It also may be that a general depression, 
anxiety, and happiness scale might not truly measure these variables, and that specific 
questions pertaining to CD must be asked.   
Casellas, Lopez Vivancos, and Malagelda (2005) investigated the effect of the GF 
diet by assessing 63 CD patients and identifying them as being in one of two groups 
based on their current compliance with the GF diet.  Fifty-four CD patients were in the 
GF diet treatment group since prior to the study they were on the GF diet, while 9 CD 
patients were considered to be in the no-treatment group since they had not begun the GF 
diet as of yet.  Compliance to the GF diet was assessed with a modified version of the 
questionnaire used by Morisky, Green, and Levine (1986), while the Spanish version of 
the Euro5D (EuroQoL-5D) and Gastrointestinal Quality of Life were used to assess 
HRQL.  Compliance to the diet in the GF diet treatment group was 79%.  There was a 
statistically significant difference between the GF diet treatment group and the no-
treatment group with the treatment group having better HRQL than the no-treatment 
group.  Further, those in the treatment group who reported “symptoms disappeared with 
the diet” reported better overall HRQL than those in the treatment group who reported 
“partial improvements only”.  Finally, the results from the EuroQoL-5D in this study 
were compared to a healthy Spanish sample.  Median scores for the treatment group were 
similar to the median scores obtained in the healthy Spanish population and median 
scores for the no-treatment group were lower than the median scores in the healthy 
Spanish population. 
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Hauser et al. (2006) conducted a national survey to assess HRQL in German CD 
patients as compared to the German population.  Questionnaires assessing HRQL (SF-
36), depression (Hospital Anxiety and Depression Scale; HADS), and bodily symptoms 
(fatigue, dyspeptic myalgia/arthralgia and cardiorespiratory) (GieBener Symptom Check 
List; GBB 24) were mailed to 1000 of the 18,355 members of the German Coeliac 
Society DZG.  Fifty two percent of the surveys were returned, with 71.7% of the sample 
being female.  The median age was 44.4 years and 45% of the sample reported having 
one or more diseases associated with CD.  The results indicated that 26% of the sample 
had symptoms of irritable bowel syndrome.  CD patients had higher anxiety scores and 
lower HRQL scores (except for physical functioning) than the general population; 
however, there was no difference between groups for the depression measure.  Pre-CD 
diagnosis, 71% rated global HRQL as “bad”; however, after diagnosis of CD and 
initiation of the GF diet, 98% reported a reduction in symptoms and 73% reported “very 
much better” or “much better” global HRQL.  The GF diet was able to help improve 
HRQL in GD patients, yet, HRQL was still significantly lower in CD patients on the GF 
diet when compared to the general German population. 
Like Hauser et al. (2006), Hallert et al. (1998) found that CD patients on a GF diet 
for 10 years had lower QoL than the general population.  Hauser et al. and Hallert et al. 
found that adherence to the GF diet is related to QoL, but that the GF diet alone does not 
make CD patients similar to the general population in terms of QoL.  Other research has 
not shown this.  For example, Roos, Karner, and Hallert (2006) found no difference in 
anxiety, depressed mood, or distress, as measured by the Psychological General Well 
 27 
Being Index (PGWB), between Swedish CD adults (n=51) and population controls 
(n=182) after the CD adults had been treated with the GF diet for 8-12 years.  However, 
the Swedish CD women in this study had a lower level of PGWB than the Swedish CD 
men. 
Using the same sample, Hauser et al. (2007) further investigated HRQL, by 
determining predictors of HRQL through a multivariate approach.  Five hundred and 
twenty-two CD individuals (78% female) participated and 41% of these were biopsy-
diagnosed.  Hauser et al. found that the adherence to the GF diet and not the duration of 
the GF diet were predictive of scores on the Celiac Disease Questionnaire (CDQ).  That 
is, those who were non-compliant with the diet were more likely to have lower scores on 
the CDQ, which measured GI symptoms, emotional well-being, social restrictions, and 
disease-related worries.   
Social and environmental factors affecting HRQL and QoL.  The definition of 
HRQL includes how content and happy individuals are with many facets of their life.  
These facets include social functioning, physical functioning and mental functioning.  In 
addition to mental functioning, social functioning is an important area of concern for 
individuals with CD.  Environmental factors influence perception of QoL and Ciacci 
(2006) mentions how sources of GF foods and the availability of GF foods in specific 
countries may impact the burden placed on CD patients.  Further, social and 
environmental factors such as the patient’s education and quality of healthcare may 
influence how a CD patient adapts to the GF diet.  One study showed how women had a 
higher perceived “burden of illness” when compared to men.  This might be due to the 
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social implications of the disease, such as shopping for food, cooking, and feeding their 
family.  This feeling of restriction in selecting foods may impact their QoL.  In addition 
to social and environmental factors, feelings of an unsatisfactory sex life (Ciacci et al., 
2003) and difficulty adapting to a chronic disease (Fera, Cascio, Angelini, Martini, & 
Guidetti, 2003) have been reported. 
Lee and Newman (2003) investigated the impact of the GF diet on QoL in 253 
CD patients (74% female).  Through mail, Lee and Newman (2003) received back 68% 
of their surveys, which were self-administered questionnaires that assessed 
demographics, lifestyle, and food choices, and asked 11 questions from the SF-36 to 
assess perceived health, impact of disease, and socialization.  The results of this study are 
interesting in that although CD patients reported that CD had no effect on their ability to 
work (81% of respondents) and that their current health was perceived as “excellent” 
(71% of respondents), 82% of CD patients reported a negative impact on other “specific” 
QoL issues (travel, family life, dining out, and careers).  Further, there where gender 
differences noted, as more women than men were impacted in all areas.  These results 
support the need to continue to assess specific CD-related QoL issues, in that general 
QoL variables, such as overall ability to work or overall health might not be the best 
predictors of QoL in CD patients.   
Doctor-patient and nutritionist-patient communication.  Access to information 
concerning how to adhere to the GF diet and knowledge about the disease also affects 
QoL and HRQL.  For example, Hauser et al. (2007) found that doctor-patient 
communication was a predictor of HRQL via the CDQ scores.  Further, there was a 
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significant correlation between the total CDQ score and both non-compliance with the 
GF diet and dissatisfaction with information received from the doctor.  That is, total CDQ 
was reduced in those who had high non-compliance and high dissatisfaction with 
information provided by their doctors (Häuser et al., 2007).  Adherence to the GF diet has 
been shown to cause lower levels of QoL, with one possible cause being the lack of 
information available to CD patients from the medical community.  Tidwell and Bomba 
(2001) showed that of the 96 CD patients who saw a dietician, 53.3% of CD patients 
rated sessions with a dietician as unhelpful and also found that 54.1% found the dietician 
to not even know about CD.  Therefore, based on this research there may be a link 
between interactions with the medical community, knowledge about the disease and GF 
diet, diet adherence, and HRQL.  Just as plausible, is that anxiety and depression impact 
diet adherence, in that high levels of anxiety and depression are associated with reduced 
GF diet adherence (Addolorato, Stefanini, & Capista, 1996).  For example, depression 
has been found to be one of the main reasons for noncompliance to treatment in chronic 
disease patients (DiMatteo, Lepper, & Croghan, 2000). 
Personality, quality of life and celiac disease.  Some research has tried to link 
personality factors to QoL in CD patients.  For example, De Rosa, Troncone, Vacca, and 
Ciacci (2004) investigated how the chronic nature of CD and the GF diet requirements 
impacted personality and diet adherence.  Twenty-nine CD patients (25 women) and 47 
control subjects were assessed with the Italian version of the Eysenck Personality 
Questionnaire and the Psychophysiological Questionnaire.  CD patients were following a 
GF diet and rated their adherence to the GF diet on a scale of 0 to 10, with 10 being that 
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they always adhered.  The CD patients, but not the controls, completed the Italian version 
of the Illness Behavior Questionnaire.  Results showed an average adherence rate to the 
GF diet of 8.63.  Duration of having the disease was an important predictor of emotional 
instability, as measured by the Eysenck Personality Questionnaire.  That is, CD patients 
who were diagnosed as children had lower emotional instability scores than those 
diagnosed later in life.  Further, CD patients were found to have higher scores on the 
irritability scale and affective inhibition scale, and higher anxious vigilance and a higher 
tendency to conform than the control subjects (De Rosa et al., 2004). 
Other complications associated with celiac disease and their impact on HRQL.  
Other complications, although not neurological in nature, affect CD patients and may 
contribute to their lower levels of HRQL, especially since they affect their mobility and 
energy or lack there of.  Osteoporosis and iron deficiency anemia are present in some CD 
patients. For example, Green and Jabri (2006) reported a prevalence of CD in 2-7% of the 
osteoporosis patients and 3-15% of the iron-deficiency anemia patients that were 
screened.  Hauser et al. (2007) found that 15% of their CD sample (n=522) had 
osteoporosis, while 10% of the sample had anemia.  Although iron deficiency anemia is 
usually corrected with the GF diet (Kupper, 2005), osteopenia and osteoporosis are 
increased in CD patients not on the GF diet, and are only sometimes stabilized in CD 
patients on a GF diet.   
Future Directions in Celiac Disease and HRQL Research 
Currently, all of the CD and HRQL research has focused on the impact of the GF 
diet on HRQL variables.  The results have been mixed in that some research has found 
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that CD patients currently adhering to the GF diet were not different from the healthy 
controls (Viljamaa et al., 2005); however, other research has found that the GF diet is at 
times able to improve HRQL, but not normalize it (Häuser et al., 2006).  Therefore, 
knowing that the GF diet may not be able to normalize HRQL in CD patients, other 
variables that have been shown to impact HRQL should be investigated in the CD 
populations.  Specifically, the influence of physical activity and aerobic fitness on CD 
patients should be explored.   
Physical Activity and Aerobic Fitness 
Defining the Terms 
Physical activity is defined as “any bodily movement produced by the contraction 
of skeletal muscle and that substantially increases energy expenditure” American College 
of Sports Medicine (2006, p.3) and is usually measured in kilocalories per unit of time 
(Casperson, Powell, & Christenson, 1985).  According to Buckworth and Dishman (2002, 
p.29) “aerobic fitness refers to the maximal capacity of the cardiovascular system to take 
up and use oxygen and is typically expressed in millimeters of oxygen per minute 
adjusted for total body mass or fat free mass expressed in kilograms”.  Based upon the 
link between physical activity (the behavior) and aerobic fitness (a reflection of genetic 
factors, physiological status, and level of physical activity), it is predicted that both may 
influence psychological outcomes in CD patients.   
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Physical Mobility and Functional Fitness 
 Physical mobility, or one’s independent ability to perform activities of daily living 
(ADL), is measured through neuromuscular examination, self-report questionnaires, 
clinical laboratory balance or sway tests, and field tests that assess movements used in 
daily living (Podsiadlo & Richardson, 1991).  Although physical ability is not our 
primary aim, the need to be able to function effectively is an important consideration 
when assessing other variables, such as physical activity levels, HRQL, and executive 
function, which are both closely related to physical functioning.  Stewart, King and 
Haskell (1993) proposed that functioning and well-being were the two broad qualities 
used to label outcomes for quality of life research.  The functioning category included 
physical abilities and ADLs.  Rejeski, Brawley, and Shumaker (1996) found that 
correlation were higher between performance-based measures of dysfunction and HRQL 
than for fitness and HRQL; therefore, measuring physical mobility might provide us with 
additional information as to what measures of physical activity or aerobic fitness are 
important as predictors.  Further, the Timed Up and Go task, our measure of functional 
fitness requires cognitive demands, specifically executive processes.  For example, a 
participant is asked to stand from a chair quickly, walk as fast as possible to a cone, turn 
around as quickly as they can, walk as fast as possible back to the chair, and sit down.  
This process requires planning (how will I get to the cone and back), formulating a goal 
(when she says, “Go”, I am going to stand as quickly as I can…), initiating that goal, self-
monitoring their behavior (did I go quickly enough?), and correcting their behavior (let 
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me try to go faster this time), if needed.  These abilities and processes are all part of 
executive functions (Salthouse, Atkinson, & Berish, 2003) 
Physical Activity, Aerobic Fitness and HRQL 
Overview 
In the CD population, the effect of physical activity and aerobic fitness on HRQL 
has not been studied.  However, there has been one pilot correlational study (see Chapter 
III) that has investigated the relationship between HRQL and satisfaction with life (SWL) 
with physical activity (Barella, Etnier, Gill, & Perry, 2008).  Further, numerous studies 
have reported the impact of physical activity on HRQL in other populations including 
older adults (Elavsky et al., 2005; Rejeski & Mihalko, 2001; Schechtman & Ory, 2001), 
cancer patients (Courneya & Friedenreich, 1999), fibromyalgia patients (Mannerkorpi, 
Nyberg, Ahlmen, & Ekdahl, 2000), chronic obstructive pulmonary disease patients 
(Katula, Rejeski, Wickley, & Berry, 2004; Lacasse et al., 1996), cardiac rehabilitation 
patients (Denollet & Brutsaert, 1995), knee osteoarthritis patients (Rejeski, Ettinger, 
Martin, & Morgan, 1998; Rejeski, Martin, Miller, Ettinger, & Rapp, 1998); people with 
cardiac disease risk factors (Taylor-Piliae, Haskell, Waters, & Froelicher, 2006), 
intensive care patients (Patrick, Danis, Southerland, & Hong, 1998),  and multiple 
sclerosis (Sutherland, Andersen, & Stoové, 2001).  
Research 
Since the effect of physical activity has not been addressed in CD patients, except 
in the case of the pilot correlational study, literature from other populations, including 
many of the above-mentioned groups, will be assessed, first by addressing literature 
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reviews on the area of physical activity and QoL or HRQL and then by assessing cross 
sectional studies and interventions.  The pilot study that assessed the relationship between 
physical activity, aerobic fitness, HRQL, and satisfaction with life (SWL) will also be 
discussed in detail.   
First, a literature review was conducted to assess the effect of physical exercise on 
a broad range of QoL and HRQL variables following a cancer diagnosis (Courneya & 
Friedenreich, 1999).  Twenty-four studies were reviewed, eighteen of which were 
interventions.  The results from 16 of the 18 intervention studies and five of the six 
descriptive studies reported a positive effect for physical exercise following a cancer 
diagnosis on physical, functional, psychological, and emotional well-being (Courneya & 
Friedenreich, 1999).  
In their review of 28 studies, Rejeski, Brawley, and Shumanker (1996) concluded 
that there was direct evidence for a relationship between physical activity and HRQL.  Of 
the 28 studies, 18 examined chronic disease populations (cardiovascular disease, 
pulmonary disease, and arthritis), while the other 10 examined asymptomatic adults.  
Age, activity status, or health of participants did not matter for improvements in HRQL to 
occur.  Rejeski et al. (1996) reported from their review that changes in fitness (VO2) did 
not impact HRQL as much as performance based measures of dysfunction.  That is, in the 
populations studied, maximal oxygen carrying capacity was not the best indicator of 
changes in HRQL.   
Social support, a domain of HRQL, may be important for health in chronic 
disease populations, especially if it can alter the impact of the illness on the patient 
 35 
(Sherbourne, Meredith, Rogers, & Ware, 1992).  In the CD population, this variable is 
extremely important given the social implications of the CD diet.  Sherbourne et al. 
(1992) examined, using a cross sectional design, how social support and stressful life 
events impact physical functioning and emotional well-being in four chronic disease 
groups (diabetes, coronary heart disease, hypertension, depression) of varying ages.  The 
Medical Outcomes Study (MOS) participants provided data for this study.  Eligible 
patients (n=1402) completed surveys that assessed HRQL, social support, and stressful 
life events.  The analyses were conducted in age groups (18-44; 45-64; and 65 years +).  
The 1402 participants from the MOS group were compared to 2181 patients of other 
medical offices.  Social support was beneficial to QoL in all age groups, with the high 
social support group having greater physical functioning and emotional well-being than 
the low social support group.  Stressful life events also impact HRQL, with the impact 
being on emotional well-being more than on physical functioning, but varying according 
to age group.  For example, only the 45-64 year olds with financial concerns experienced 
a lower physical functioning and emotional wellbeing at baseline and over time than 
those 45-64 year olds without financial concerns.  Finally, relationship events (serious 
arguments, divorce or termination of a relationship) only impacted emotional well-being 
and all age-groups who experienced relationship events had lower emotional well-being 
at baseline than those who did not experience relationship events.   
In addition to the chronic disease conditions investigated by Sherbourne et al. 
(1992), HRQL has been found to be hampered in Fibromyalgia Syndrome (FMS) 
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patients, chronic obstructive pulmonary disease patients, and patients with multiple 
sclerosis (MS). 
FMS symptomatically appears in patients as fatigue, pain, stiffness, and 
functional limitations.  Fatigue is also a symptom experienced by CD patients; therefore, 
Mannerkorpi et al. (2000) reported on the effects of a physical activity intervention in 
FMS patients.  Fifty-eight women (mean age = 46 years) with FMS participated in either 
6-months of 35-minute pool sessions and six 1-hour education sessions or the control 
condition.  Mannerkorpi et al. used both self-report questionnaires (Fibromyalgia Impact 
Questionnaire (FIQ), SF-36, Swedish version of the Multidimensional Pain Inventory, 
The Arthritis Self-Efficacy Scales, The Arthritis Impact Measurement Scales, and The 
Quality of Life Questionnaire) and physical activity assessments (6-minute walk test, 
chair test, shoulder range of motion, grip strength, shoulder abductor endurance) at pre-
intervention and at the end of the study.  The chair test was used to assess lower body 
endurance and required the participant to stand up and sit down as fast and as many times 
as possible in one minute (Mannerkorpi et al., 2000; Mannerkorpi, Svantesson, Carlsson, 
& Ekdahl, 1999). 
Significant differences were found for the 6-minute walk test between the 
exercise and control groups.  Further, the exercise group performed better on the FIQ 
total and FIQ physical functioning scores.  Finally, when comparing the exercise to 
control groups, the exercise group had significant improvements in SF-36 general health, 
SF-36 social functioning, anxiety, and affective distress.  When with-in effects were 
assessed, the exercise training group had improvements from pre- to post-6-month 
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intervention in physical functioning, bodily pain, general health, vitality, and social 
functioning domains on the SF-36.  Fatigue and anxiety also improved.  Since the aerobic 
training program was combined with an education component, it is impossible to 
determine the specific influence of the aerobic training component on the changes 
observed.   
Other medical conditions, such as, chronic obstructive pulmonary disease 
(COPD), have benefited from exercise training (Lacasse et al., 1996).  Lacasse et al. 
(1996) conducted a meta-analytic review of COPD patients involved in randomized 
controlled trials that involved at least 4-weeks of exercise training and assessed either 
functional or maximal exercise capacity and/or HRQL.  The randomized controlled-trials 
were classified according to the exercise setting, component of the intervention, duration 
of the intervention, exercise capacity outcome, and HRQL outcome.  Fourteen trials were 
included in this analysis.  Twelve of the 14 trials assessed HRQL, 11 of the 14 trials 
(n=309 patients) measured maximal aerobic capacity and 11 of the 14 trials (n=413 
patients) measured functional exercise capacity.  The HRQL analyses were limited to 
studies that included two instruments, the transitional dyspnea index and the chronic 
respiratory index.  Lacasse et al. (1996) justified this limitation by noting that only these 
two instruments have published validity and reliability; however, that assessment might 
not be accurate since the Profile of Moods (POMS) and others have published validity 
and reliability.  The effect of respiratory rehabilitation on dyspnea (ES=0.8), fatigue 
(ES=0.6), emotional function (ES=0.5), and mastery (ES=0.6) were found.  All of these 
effects for the QoL outcomes exceeded the minimally clinically important difference; 
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therefore, providing clinical evidence supporting of the benefits of the rehabilitation 
program. 
Although patients with multiple sclerosis (MS) are often told not to exercise, 
participating in aerobic exercise may help lessen fatigue symptoms, which have been 
found in MS patients (Sutherland et al., 2001).  Sutherland et al. (2001) investigated if 
10-weeks of aerobic exercise were able to affect psychological well-being and HRQL.  
Twenty-two MS patients were randomly assigned to either the exercise condition, which 
consisted of a submaximal exercise test on a cycle ergometer pre- and post-intervention, 
followed by 10-weeks of supervised water-based training sessions (3X/week for 45 
minutes each session), or the control condition.  HRQL was measured using The Multiple 
Sclerosis Quality of Life-54 (Vickrey, Hays, Harooni, Myers, & Ellison, 1995), which 
contains all questions from the SF-36 and items specific to MS patients.  Mood was 
measured with the Profile of Mood States – Short Form (POMS-SF) (Shacham, 1983), 
while social support was measured with the Multidimensional Scale of Perceived Social 
Support (MSPSS) (Zimet, Dahlem, Zimet, & Farley, 1988).  When the exercise group 
was compared to the control group, the largest effects were found for energy (η2 =.51) 
and vigor (η2 =.55).   
In addition to chronic disease populations, physical activity has been shown to 
increase QoL in older adults (Elavsky et al., 2005; Rejeski & Mihalko, 2001).  For 
example, Ettinger et al. (1997) investigated QoL (self-reported disability score, knee pain 
score, performance measures of physical function, x-ray score, aerobic capacity, and knee 
muscle strength) in 439 older adults, with knee osteoarthritis, who were part of The 
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Fitness Arthritis and Seniors Trial (FAST).  Participants were randomized to one of three 
groups, aerobic training, resistance training, or a health education control group.  The 
results of this randomized clinical trial showed that older adults with knee disability who 
participated in either the aerobic conditioning or resistance training condition reported 
lower physical disability, lower knee pain, better 6-minute walk test, better time to climb 
and descend stairs, better time to lift and carry 10 lbs, and better time to get in and out of 
the car than the health education group. 
Gill, Williams, Williams, Butki, and Kim (1997) investigated the relationship 
between physical activity and psychological well-being in 130 healthy older women 
(mean age = 74.8 years) using demographic, activity efficacy, health and well-being, 
general well-being, and activity measures.  More than half of the sample (n=63) had 
fallen.  Forty-five participants participated in organized exercise 2-3 times per week, 
while 96 participants walked about 4.4 times per week.  The results showed that overall, 
higher total activity predicted greater psychological well-being, age was not related to 
well-being, and activity was correlated stronger with the health and well-being ratings 
and activity efficacy than general well-being. 
In addition to chronic disease populations, and older adults, QoL has also been 
investigated in younger, healthy adults.  Specifically, King, Taylor, Haskell, and DeBusk 
(1989) tested 120 sedentary healthy middle-aged adults who were randomized to either 
the treatment or control condition.  If randomized to the treatment condition, participants 
completed a 6-month home-based aerobic exercise program which consisted of 
approximately 47-54 minutes at 65% to 77% of peak baseline treadmill heart rate.  At 
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baseline and 6-months, body weight and oxygen uptake were measured.  Psychological 
measures were assessed at baseline and biweekly, for a total of 13 scores.  A 14-item 
rating scale developed for this research study was used.  When compared to the controls, 
the exercise condition showed significant improvements in the mean rates of change and 
actual mean ratings across time in satisfaction with current shape and appearance, current 
physical fitness level, and satisfaction with current weight (King et al., 1989).  Even 
when expectations for change were used as a covariate in the analysis, these three 
remained significant.  Most interesting was that the change in VO2 max was not 
correlated with any of the other measures, except body weight.  Therefore, aerobic fitness 
may not be the mechanism that is causing these changes in psychological health.  Other 
factors, such as perceived body image and social support during exercise could be 
important in predicting psychological health.   
Finally, HRQL and SWL were assessed in CD patients during a pilot/preliminary 
study.  The preliminary study was split into two phases, with Phase 1 (N=47), ages 18 to 
71 yrs (M=47.19, SD=14.62), assessing the relationship between HRQL and SWL with 
physical activity, as measured by MET hours per week and number of vigorous bouts of 
physical activity per week, and Phase 2 (N=9), ages 41 to 71 yrs (M =55.33, SD = 9.77), 
assessing HRQL and SWL with aerobic fitness, measured with a VO2 max test.  In Phase 
1, there was a statistically significant correlation (r=.70) between bouts of vigorous 
physical activity and the HRQL composite.  In Phase 2, moderate positive correlations 
were found for VO2 peak with the SF-36 aggregate physical component score.  MET 
hours per week did not strongly predict HRQL or SWL in either phase.  Additional 
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research is needed to explore why relationships are being found for vigorous bouts of 
activity and not MET hours per week.  Further, a larger sample size is needed to test the 
relationship between VO2 peak and HRQL, to determine what relationships emerge when 
the study has sufficient power.   
Physical Activity, Aerobic Fitness, and Cognition 
Overview 
The effects of aerobic fitness on cognitive function have been investigated in all 
age groups by correlation, cross-sectional and experimental design studies conducted in 
human and animal models.  Although most cross-sectional data support the beneficial 
effect of aerobic fitness on cognition, intervention studies are more variable.  Further, 
correlation and cross-sectional studies do not manipulate aerobic fitness; therefore, they 
cannot be interpreted exactly like findings from intervention studies, where aerobic 
fitness is manipulated (Etnier, Nowell, Landers, & Sibley, 2006).   
Theories guiding research on aerobic fitness and cognition include the 
cardiovascular fitness hypothesis, the cognitive reserve hypothesis, and the executive 
control hypothesis.  The cardiovascular fitness hypothesis predicts that aerobic fitness 
mediates the relationship between physical activity and the health benefits obtained 
(North, McCullagh, & Tran, 1990) and cognitive performance (Etnier, 2008).  Another 
theory is the cognitive reserve hypothesis.  Cognitive reserve is simply how the brain 
stays resilient to damage, while using what resources it has available in the most 
efficacious way possible.  The hypothesis proposes that physical activity may provide 
more benefits for individuals with limited cognitive reserves (Chodzko-Zajko & Moore, 
1994; Etnier & Landers, 1998).  Finally, the executive control hypothesis states that 
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physical activity will benefit those tasks which require executive control (effortful 
processing) compared to those tasks which are automatic.  Therefore, in addition to older 
adults who have limited cognitive reserves due to aging and/or age-related declines in 
executive control process, chronic disease populations with known neurological 
complications from their disease state might also benefit from physical activity. 
For the purpose of this literature review, the focus will be on the executive control 
hypothesis and executive function tasks used to measure cognitive function.  Executive 
function consists of capabilities, such as volition, initiation, planning, purposive action, 
self-monitoring, and self-regulation, which enable adults to act appropriately and 
independently (Lezak, Howieson, & Loring, 2004).  Conceptually, executive function is 
one of the three dimensions of behavior, with executive function being how a behavior is 
expressed, and cognition and emotionality, being how information is handled, and 
feelings about this information, respectively (Lezak et al., 2004).  Executive functions 
differ from cognitive functions in that they are a behavior that results from “how” or 
“whether” a person does something, versus “what” or “how much” a person does (Lezak 
et al., 2004).  When executive functions are hampered, the ability to carry out cognitive 
tasks becomes compromised.  
Executive function is associated with the frontal and parietal regions of the cortex 
(Kramer et al., 1999) and aerobic fitness has been shown to preserve the integrity and 
structure of the gray and white matter tracts in the frontal, parietal, and temporal cortices 
(Colcombe, Kramer, Erickson et al., 2004).  Further, Colcombe et al.’s (2003) research 
on aerobic fitness and brain tissue loss is consistent with these findings in that aerobic 
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fitness spared cortical density loss in older adults in the gray matter in the frontal, 
temporal, and parietal lobes and in the white matter tissue in the anterior and posterior 
tracts. 
Mechanisms 
A moderator and mediator are 3
rd
 variables that might impact the relationship 
between the dependent and independent variables (Baron & Kenny, 1986).  A moderator 
is categorical or continuous and affects the direction of the relationship, while a mediator 
(mechanism) exhibits indirect effects and is usually either a variable that represents a 
broad construct (mediator) or a more quantifiable construct (mechanism), such as number 
of neurons (Etnier, 2008).  Etnier (2008) reported that moderators of the relationship 
between physical activity and cognition in older adults include age, gender, estrogen 
status, APO E-4 genotype and depression.  Mediators or mechanisms can be detected 
with statistical tests and may be represented in a variety of causal chains (single and 
multiple micromediational).  Further, mediators can be represented as psychological 
(quality of life, motivation), behavioral (eating patterns), disease state (type of disease), 
and physiological (hormones, neurotransmitters); however these mediating relationships 
are seldom tested (Etnier, 2008; Etnier et al., 2006).  
Etnier et al. (1997) suggested three possible mediators or mechanisms, increased 
cerebral blood flow, increased neurotransmitters, and permanent structural changes in the 
brain, to explain the relationship between aerobic fitness and cognitive function.  For 
example, the cerebral circulation hypothesis proposes that oxygen transport in the brain is 
enhanced with chronic exercise.  This enhancement in oxygen transport may result in 
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better cognitive performance due to an increased availability of resources (Chodzko-
Zajko & Moore, 1994).  
Increased neurotransmitters, structural changes in the brain, and the impact of 
hormones on brain changes have been shown mostly through animal models.  For 
example, aerobic training has been found to improve plasticity and neuronal survival 
through increases in brain-derived neurotrophin factor (BDNF) (Neeper, Gómez-Pinilla, 
Choi, & Cotman, 1995).  Cotman and Engesser-Cesar (2002) used animal models to 
show that voluntary wheel running in rats increased mRNA for BDNF.  BDNF has been 
found to increase levels of the proteins needed for neuronal synapses, which are needed 
for cognitive function, and is therefore an important component of neuronal 
communication.  Cameron and McKay (1999) noted that cell proliferation rates can 
increase in aged animals if cortisol levels are decreased.  Both animal studies (Berchtold, 
Kesslak, Pike, Adlard, & Cotman, 2001) and human studies (Erickson et al., 2006) 
suggest that estrogen might be an important predictor of the outcomes of aerobic fitness.  
For example, Colcombe et al. (2003) found that females who exercised and were on 
hormone replacement therapy (HRT) had a greater increase in cortical density than those 
not on HRT.  Berchtold et al. (2001) found that the rate of BDNF transcriptions is 
increased in aged animals when estrogen is present.   
Other hormones, human growth factor (HGF) and insulin-like growth factor 
(ILG-1), that are released during strength training may impact and heighten the effects of 
aerobic training in older adults, through their effects on neuronal growth, differentiation, 
and performance (Colcombe, Kramer, McAuley, Erickson, & Scalf, 2004).  
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Research 
The results of the correlational, cross sectional, prospective/retrospective, and 
intervention studies and those of the meta-analyses, although not specific to CD, are 
important as they help us understand how physical activity may impact cognitive function 
in CD patients.  Further, symptoms/disease implicated in other populations studied, such 
as dementia in older adults or fatigue in FMS patients, are relevant when investigating 
how physical activity may impact cognition in CD patients.  Finally, the literature also 
gives us information on which types of tests (physical activity, aerobic fitness and 
cognition) were valid and reliable and types of methodical issues that other researchers 
may have experienced.  Therefore, meta-analytic reviews, literature reviews, 
correlation/cross-sectional, prospective/retrospective, and randomized controlled 
studies/trials that are relevant to CD will be discussed.  These will include older adult and 
chronic disease populations and relevant prospective/retrospective studies. 
Meta-analyses.  Meta-analyses conducted in this area have focused on elderly 
persons with cognitive impairment (Heyn et al., 2004), healthy and sedentary older adults 
(Colcombe & Kramer, 2003), children (Sibley & Etnier, 2003), and across all ages 
(Etnier et al., 2006; Etnier et al., 1997).  These meta-analyses consistently show that 
chronic physical activity positively impacts cognitive performance. 
Based on previous experimental research in humans and animals, it was 
hypothesized by Etnier et al. (1997) that chronic training programs or cross-sectional 
designs that compared fit to unfit would have the largest effect sizes and that exercise 
would most benefit the mentally impaired and older adults who may be resource limited.  
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Exercise was categorized as acute, chronic, mixed, cross-sectional/correlational and 106 
different cognitive assessments were used in the studies analyzed.  The larger effect 
found for the cross-sectional / correlation exercise studies supports the first hypothesis, 
while the prediction that those with reduced mental ability would have larger effects was 
not supported in both the acute and chronic studies, since mental ability was not a 
significant moderator.  When age group was assessed, it was not a significant moderator 
in the acute studies; however, it did significantly impact effect size in the chronic studies.  
However, the college age group had significantly larger effects than the oldest age group 
and therefore, the hypothesis that older adults might have larger effects was not 
supported.  The overall effect sizes were .53 for cross-sectional/ correlation exercise, .33 
for chronic exercise, and .16 for acute exercise.  An overall effect size of .18 was reported 
for randomized experimental designs.  These effect sizes are important as they help 
develop an approximation of the types of effects that could be found when investigating 
aerobic fitness in CD patients. 
Colcombe and Kramer (2003) conducted a meta-analytic review and included 
healthy and sedentary older adults, with an average age of 55 years, from 18 intervention 
studies.  Cognitive processes were categorized according to four theoretical areas, speed, 
visuospatial, controlled processing, and executive control.  Exercise was found to have 
the greatest effect on executive processes (ES =.68), and combined strength and aerobic 
training were better than aerobic training alone (.59 vs. .41).  Long duration training 
programs had the largest effect (.67), while both moderate bouts and long bouts both had 
significant effects (.61 and .47).  Age moderated the relationship in that the 66 to 70 year 
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olds experienced the largest benefits.  Finally, groups that contained greater than 50% 
females had larger benefits than those with less than 50% females.  Participant 
characteristics, type of training, and type of cognitive task did not impact the effect size.  
Also, when changes in VO2 max were categorized (no change, 5-11% change, and 12-
25% change) and assessed, effect sizes were not significantly altered based on these VO2 
levels.   
Heyn et al. (2004) conducted a meta-analysis that focused on older adults (greater 
than 65 years of age) with cognitive impairment and dementia.  Dementia has been 
implicated in CD patients, so it is helpful to assess the results of this meta-analysis.  
Thirty randomized trials (72% women) were assessed and the overall mean effect size 
was 0.62.  Cognitive performance effects were 0.57.  Heyn et al.’s (2004) meta-analysis 
had limitations, including the inclusion of studies with a small sample size, lack of 
blinding procedures, and lack of clarity if exercise intensity was maintained throughout 
the study.  Although criticized, it still sheds light on the potential impact of exercise 
training on the elderly with dementia. 
The purpose of Etnier et al.’s (2006) meta-regression analysis was to statistically 
examine the relationship between aerobic fitness and cognitive performance using 
regression techniques that assess dose-response or the degree of influence of aerobic 
fitness on cognitive performance.  An overall effect size of 0.34 was found for cognitive 
performance.  In the cross-sectional and pre-post studies, age interacted with aerobic 
fitness.  No relationships between aerobic fitness and cognitive performance were found 
for the cross-sectional and post-test studies; however, a negative relationship was found 
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in the pre-post studies.  Only the correlation studies provided a positive effect (r=0.29).  
Overall, results of the meta-regression were not found to support the cardiovascular 
fitness hypothesis.  Etnier et al. (2006) concluded that other factors need to be explored, 
in that aerobic fitness may not predict cognitive performance or may only partially 
predict it.  Possible explanations were given to explain why aerobic fitness did not predict 
cognitive function.  It was thought that maybe aerobic fitness is not a precise enough 
measure and therefore cannot capture all of the physiological changes that occur in 
response to chronic exercise.   
Randomized controlled trials.  While there are many randomized controlled trials 
which show the benefits of aerobic exercise on cognition, Colcombe et al. (2004) is of 
particular interest since the research design employs older adults, the Rockport 1-mile 
walk, and cognitive testing that assesses executive function.  Colcombe et al. (2004) 
investigated cortical plasticity in two studies, a cross-sectional assessment and a 
randomized clinical trial.  VO2 max was estimated based on the participants’ 
performances in the Rockport 1-mile walk test.  Cognitive testing was conducted using 
the Erickson Flankers Task and functional magnetic resonance imaging (fMRI) was used 
to assess cerebral activity during task performance.  In the randomized controlled trial, 29 
participants completed the Erickson Flankers Task 1-week pre-intervention and 1-week 
post-intervention.  The participants were randomly assigned to one of two groups for 6-
weeks, either the aerobic group or the stretching and toning group (control).  Results of 
the randomized controlled trial showed that the aerobic group increased their 
cardiovascular fitness by 10.2%, while the control group only increased by 2.9%.  
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Although the Erickson Flanker Test results were not significant, the aerobic group 
experienced an 11% decrease in interference, while the control group only experienced a 
2% decrease in interference.  The fMRI results for the randomized controlled trial 
indicated that the aerobic group had greater activation in areas associated with attention 
(Colcombe, Kramer, Erickson et al., 2004).  Finally, when the aerobic group was 
compared to the control, there was significantly less activity in the anterior cingulate 
cortex (ACC) (Colcombe, Kramer, Erickson et al., 2004). 
Cross Sectional.  The investigation by Colcombe, Erickson, Raz, Webb, Cohen, 
McAuley et al. (2003) is important since it examined the effects of cardiovascular fitness 
on cortical density in older adults aged 55-79 years.  Loss of white matter density has 
been implicated in CD patients; therefore, this study informs of the beneficial effects of 
aerobic fitness on this brain area.  This cross-sectional study examined the gray and white 
matter tracts and found fitness was a significant moderator of cortical tissue loss.  The 
areas most affected were gray matter in the frontal, temporal, and parietal lobes and white 
matter tissue in the anterior and posterior tracts (Colcombe et al., 2003).  
The research design in Colcombe et al. (2004) helps inform the current research 
study since it uses the Rockport 1-mile walk and executive function tests.  In Colcombe 
et al (2004), cortical plasticity was investigated in two studies, a cross-sectional 
assessment and randomized clinical trial.  In the cross sectional assessment, 41 older 
adults completed the Rockport 1-mile walk test, and cognitive testing using the Erickson 
Flankers Task and fMRI.  Participants were split (high fit, low fit) based on the median of 
their estimate VO2 max test, derived from the Rockport 1-mile walk test.  The results of 
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the Erickson Flanker’s task showed that high fit older individuals performed better with 
the conflict cues ( i.e., reduction in behavioral conflict) than the low fit older adults, 
while the fMRI showed that high fit older adults had greater effective attentional control 
(Colcombe, Kramer, Erickson et al., 2004). 
Prospective and retrospective.  In addition to cross-sectional and correlational 
studies, prospective and retrospective designs have been used to assess cognitive 
function; however, physical activity and not aerobic fitness is typically assessed.  In 
prospective studies, physical activity is measured and then the participants are followed 
over months or years to determine if changes in cognition occur with time.  Retrospective 
studies are designed to measure current cognitive function and then look back in time to 
assess physical activity levels.   
Of the prospective studies that have examined cognitive performance outcomes, 
most support the beneficial effect of physical activity on cognition (Albert et al., 1995; 
Barnes, Yaffe, Satariano, & Tager, 2003; Dik, Deeg, Visser, & Jonker, 2003; Lytle, 
Vander Bilt, Pandav, Dodge, & Ganguli, 2004; van Gelder et al., 2004).  Dik et al. (2003) 
was the only prospective study with cognitive performance outcomes that failed to 
support the benefit of physical activity on cognitive performance.  This lack of support 
was likely due to their physical activity measure, which asked participants (n=1,240) to 
recall physical activity from 50 years earlier and then used to measure and predict future 
changes in cognition.  Lytle et al. (2004) used a self-report measure (three levels of 
exercise) and found strong support for high exercise level (>= 30 minutes; >=3x/week) 
being protective against cognitive decline.  Yaffe, Barnes, Nevitt, Lui, and Covinsky 
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(2001), also used a self-report measure, but assessed total kilocalories of energy 
expended per week as their measure, instead of exercise level.  The authors found that 
compared to the lowest quartile, the highest quartile had a 35-37% less risk of cognitive 
decline.  Further, for every 1700 kcal of energy expended, there was a 14% less risk of 
decline.  In the prospective studies that measured clinical outcomes, such as dementia 
risk (Abbott et al., 2004; Laurin, Verreault, Lindsay, MacPherson, & Rockwood, 2001), 
cognitive function in nurses (Weuve et al., 2004) and Alzheimer’s Disease (AD) (Lindsay 
et al., 2002; Wilson et al., 2002), all but Wilson et al. (2002) showed support for the 
benefits of physical activity.  The studies that supported a relationship generally found 
physical activity to be positively related to cognition and negatively related to disease 
risk.  Wilson et al. (2002) did not find physical activity level (weekly hours of physical 
activity) to be related to AD risk.  However, this might be due to the failure to assess 
disease magnitude/status at baseline and the failure to assess past cognitive activities, 
which would more likely be associated with a decreased risk of AD than current 
cognitive activities.   
Summary 
CD is an autoimmune condition, which is triggered by ingestion of gluten, and 
requires lifelong adherence to the GF diet to minimize symptoms.  Those with CD have 
been found to experience lower levels of HRQL than the general population, even when 
adhering to the GF diet.  Neurological studies have reported brain atrophy and dementia, 
both of which affect executive function.  There are few behavioral studies that have used 
cognitive tests to assess executive function in CD patients.  Physical activity has been 
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investigated in other chronic disease populations and has been shown to be positively 
predictive of HRQL and cognition in cross-sectional studies, and influential on HRQL 
and cognition in experimental studies.  However, the results for aerobic fitness are mixed 
in that aerobic fitness has not always impacted HRQL or cognition in experimental 
designs.  This may indicate that changes in aerobic fitness are not necessarily the 
mechanism driving the changes in HRQL or cognition.  There are not any studies to date 
that have investigated how physical activity and aerobic fitness are related to HRQL and 
executive function in CD patients; therefore, knowing that cognition may be improved in 
other populations studied (chronic disease, older adults) as a result of physical activity, 
and in some cases, aerobic fitness, supports the need for a research study that investigates 
how both physical activity (self-report) and aerobic fitness (estimated from a submaximal 
test) relate to executive function in CD patients. 
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CHAPTER III 
 
PILOT STUDY 
 
 
Purpose 
 
 The purpose of this section to is describe pilot work that was conducted on the 
relationship of physical activity and aerobic fitness with HRQL, satisfaction with life, and 
depression. The results of this pilot study were used to inform the methods used in the 
current study, 
Hypotheses 
 In Phase 1 of the pilot study, relationships between physical activity and 
psychological variables were assessed.  It was hypothesized that higher physical activity 
(MET hours/week and number of vigorous bouts of physical activity/week) would be 
associated with higher HRQL and SWL and lower depression.  In Phase 2, aerobic fitness 
was assessed in a smaller sample to provide exploratory evidence regarding the 
potentially differential effects of physical activity (the behavior) and aerobic fitness (the 
physiological response to regular moderate physical activity) on the psychological 
outcome variables.  It was hypothesized that higher aerobic fitness would be associated 
with higher HRQL and SWL and lower depression. 
Participants 
 
In Phase 1, community-dwelling adults with CD, were identified and recruited to 
participate in the study through local and national CD support groups, an advertisement 
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on the Gluten Intolerance Group website, local newspapers, presentations at support 
group meetings, and flyers posted at local health food stores.  The researchers asked that 
all participants be biopsy-diagnosed with CD by a medical doctor; however 5 of the 47 
who completed Phase 1 of the research study had only been diagnosed by blood tests.  
Although, an intestinal biopsy is the gold standard for CD diagnosis (Green et al., 2001), 
sensitivity and specificity for blood test can range between 53-100% and 42-100%, 
respectively.  Therefore, results were examined with and without these five participants.  
Results did not differ when these participants were excluded from the analyses; therefore, 
these 5 participants were included in all statistical analyses and all results are presented 
with these 5 participants included.   
Participants in Phase 1 received a hard copy of the survey packet by mail or in 
person, and were asked to complete the survey at home and to return it to the principal 
investigator in the self-addressed stamped envelope.  Sixty-five surveys were given out 
and 47 were returned for a response rate of 72%.   
In Phase 2, the participants were identified and recruited to participate through the 
participant pool in Phase 1 and through the same methods as described in Phase 1.  In the 
Phase 1 surveys, participants were asked if they wanted to participate in Phase 2.  If they 
indicated yes (N=17), then they were recruited for Phase 2.  These participants were 
screened according to the guidelines of the American College of Sports Medicine 
(American College of Sports Medicine, 2006) and using the Physical Activity Readiness 
Questionnaire (PARQ).  To qualify for the study, participants had to be healthy enough to 
perform a maximum exercise bout on the treadmill.  Six of the 17 from Phase 1 who 
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volunteered to participate in Phase 2 met the inclusion criteria.  Six new participants were 
recruited by the same means used in Phase 1 for an initial total of 12 participants.  Three 
of the participants were dropped from the analyses due to incomplete data, for a total of 9 
participants in Phase 2. 
Materials 
The survey packet used in both phases consisted of six questionnaires.  The first 
questionnaire, General Health and Demographics Questionnaire, was developed by the 
principal investigator, and was used to obtain information about CD diagnosis, GF diet, and 
demographics.  HRQL was measured using the Medical Outcomes Study Health Survey, the 
Short Form 36 (SF-36) (Ware & Sherbourne, 1992) and the Health and Well-being 
Ratings (HWB) (Gill et al., 1997; King et al., 1989).  SWL was measured using the 
Satisfaction with Life Scale (Diener, Emmons, Larsen, & Griffin, 1985).  Depression was 
measured with the Beck Depression Inventory II (Beck, Steer, & Brown, 1996).  Physical 
activity was measured using the Aerobics Center Longitudinal Study Physical Activity 
Questionnaire (Kohl, Blair, Paffenbarger Jr., Macera, & Kronenfeld, 1988).  All surveys 
have well-established and acceptable psychometrics, except the HWB ratings, which are 
single items with no psychometrics reported. 
MET hours/week were determined using The Compendium of Physical Activities 
Tracking Guide (Ainsworth, 2002; Ainsworth et al., 2000), which assigns MET values to 
activities based on duration, intensity, time and type of physical activity in three areas: 
exercise, household activities, and lawn/gardening activities.  Number of vigorous bouts 
of physical activity/week was determined by the response to question #2 on the survey, 
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“How many times a week do you engage in vigorous physical activity long enough to 
work up a sweat? ________(times per week)”  One subject answered, “sometimes” and 
that data was not included in the analysis. 
 In Phase 2, the PARQ was used to assess whether or not the participant met the 
inclusion criteria.  If approved to participate, participants were asked to avoid 
consumption of caffeine and exposure to second hand cigarette smoke three hours prior 
to their laboratory visit.  It was also requested that they not exercise on the day of their 
testing and only participate in light to moderate exercise two days before their testing.   
Procedures 
In Phase 1, participants completed the surveys at home and returned them to the 
principal investigator in the self-addressed stamped envelope. 
In Phase 2, informed consent was obtained upon arrival to the University.  This pilot 
study was approved by the Institutional Review Board at the University.  Each participant 
completed the surveys within one week of completion of the VO2 max test.  A Quinton 
TM65 Treadmill equipped with safety rails, a Quinton Q-stress EKG system, a 
Sensormedics VS 29c Cardiopulmonary Exercise metabolic cart, and Polar Heart Rate 
monitors were used during the aerobic fitness test.  Weight was obtained through self-
report.  Participants were given directions and information about the aerobic fitness test and 
then moved to the treadmill for the VO2 max test.  Next, EKG electrodes, the Polar Heart 
rate monitor, and the head gear and face mask were put on the participant.  A physician was 
present for all testing.  The Astrand protocol was used and at the end of each stage, 
perceived exertion was measured using the Borg Rating of Perceived Exertion Scale 
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(Borg, 1998).  Participants reached their VO2 peak within 9-14 minutes.  VO2 max was 
considered to have been achieved if a plateau in VO2 occurred with an increase in 
workload or if the following two criteria were met: 1) a respiratory exchange ratio at test 
termination of >1.15, or 2) a heart rate (HR) at test termination > 90% of age-predicted 
maximal heart rate (220-age).  Not all subjects were considered to have reached VO2 
max, according to the criteria; therefore, the measure of aerobic fitness is most accurately 
described as VO2 peak.  The testing was done following the guidelines of the American 
College of Sports Medicine (American College of Sports Medicine, 2006).  After 
completion of the test, the treadmill was lowered to 0% grade and the speed reduced to 
2.0 mph and participants continued to walk to cool down for ≥ 5 minutes.  HR was 
monitored to ensure that the value stabilized before the participant was permitted to leave 
the laboratory.  
Twelve subjects were tested during Phase 2; however, only data for nine subjects 
are included.  One subject did not complete the surveys, one subject stopped the test due 
to feeling claustrophobic with the face mask gear, and one subject’s data was not saved 
properly.  
Statistical Analyses 
To analyze the Phase 1 HRQL data, a linear composite of the eight SF-36 
subscales and the HWB score was created using canonical correlations.  Separate 
canonical correlations were conducted for each measure of physical activity (MET 
hours/week, bouts of vigorous physical activity/week).  Bivariate correlations were 
conducted to examine relationships between the physical activity measures and 
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depression and SWL.  A Bonferroni correction was used because four separate analyses 
were conducted; thus, correlations were considered significant if p < .013.   
In Phase 1, additional bivariate correlations were conducted to explore the 
relationships between the two physical activity variables (MET hours/week and bouts of 
vigorous physical activity/week) with the individual subscales of the SF-36 and the HWB 
rating.  The purpose was to identify the directions of the relationships on an exploratory 
basis, and no significance tests were conducted.   
Finally, for Phase 1, the sample data was compared to normative data and/or 
interpretation scales from healthy populations for the SF-36 measures, Satisfaction with 
Life, Health and Well-Being ratings, BDI-II, and physical activity. 
The small sample size (N=9) for the Phase 2 data did not allow canonical 
correlations to be conducted; therefore, bivariate correlations were conducted for VO2 
peak with depression, HRQL (all SF-36 subscales and HWB score) and SWL.  
Significance was tested; however, because Phase 2 is exploratory, corrections for 
multiple tests were not made.  The strength of the correlations and effect sizes are 
reported.  Finally, for Phase 2, the sample data was compared to normative data on 
aerobic fitness. 
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Results: Phase 1 
Age, biopsy status, gender, and GF diet adherence information for 47 CD patients 
aged 18 to 71 yrs (M=47.19, SD=14.62) is presented in Table 2.  Descriptive statistics for 
all variables are presented in Table 3.  
 
Table 2 
Age, Biopsy Status, Gender, GF Diet Adherence Information and Mean Vigorous Bouts 
of Physical Activity/Week, MET Hours/Week, and VO2 Peak 
 
Phase  
Participation Phase 1 (N) Phase 2 (N) 
N 47 9 
Male 10 2 
Female 37 7 
Biopsy/Endoscopy Diagnosis 42 9 
Yes to GF Diet Adherence Within Past 2-
weeks 
45 9 
100% Adherence 30 3 
90% Adherence 15 5 
75% Adherence 2 1 
   
 
Measure of variable 
Phase 1 
M(SD) 
Phase 2 
M(SD) 
Age 47 (14.62) 55 (9.77) 
Vigorous Bouts of Physical Activity/Week 3.35 (2.60) 2.94 (2.31) 
MET hours/week 51.74 (33.91) 75.38 (46.06) 
VO2 max n/a 29.97 (10.06) 
Median VO2 max n/a 25.90 (10.06) 
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Table 3 
Phase 1 Means (Standard Deviations) for Physical Activity, HRQL, and Mental Health 
Measures 
 
 
Variables 
N
a
 Mean 
Standard 
Deviation 
    
Category A 
    
MET hours/week 47 51.74 33.91 
Vigorous Bouts of PA/week 46 3.35 2.60 
SF-36 Physical Functioning 46 50.12 8.68 
SF-36 Role Personal 47 46.64 11.65 
SF-36 Bodily Pain 47 48.05 11.16 
SF-36 General Health 47 46.45 11.18 
SF-36 Vitality 47 48.30 11.50 
SF-36 Social Functioning 46 45.94 11.27 
SF-36 Role Emotion 45 47.76 12.48 
SF-36 Mental Health 47 48.15 11.58 
SF-36 Physical Component Score 46 48.92 9.84 
SF-36 Mental Component Score 46 46.83 13.33 
Health and Well-Being Rating 47 22.09 4.88 
Satisfaction with Life Scale 47 23.15 8.33 
BDI-II* 47 10.64 8.93 
Note. *higher score is worse (i.e. more depression). 
a
 indicates a difference in N’s are due 
to incomplete data 
 
 
Relationships between physical activity variables and psychological variables 
The correlation between bouts of vigorous physical activity/week and the HRQL 
(SF-36 & HWB) composite was statistically significant (Rc=.70).  For MET hours/week, 
there was a moderate positive correlation that was not statistically significant (Rc=.37). 
The moderate, positive correlation (r=.32) between bouts of vigorous physical 
activity/week and SWLS was not statistically significant after a Bonferroni correction, 
and MET hours/week was not related to SWL.  
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 No significant relationships were found for bouts of vigorous physical 
activity/week or MET hours/week with depression. 
The correlations for the Phase 1 bivariate correlations between physical activity 
variables and SF-36 subscales and HWB rating are presented in Table 4.  These bivariate 
correlations were conducted for exploratory purposes and significance was not 
considered.  There was a moderate positive correlation (r=.36) between MET hours/week 
and bouts of vigorous physical activity/week. 
MET hours/week was not strongly related (r<.20) to any of the HRQL variables 
or SWLS.  However, bouts of vigorous physical activity/week were moderately 
positively related to SF-36 physical functioning (r=.53), SF-36 role personal (r=.51), and 
HWB ratings (r=.46).   
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Table 4 
Correlations for Measures of Physical Activity and Aerobic Fitness with Psychological 
Outcomes 
 
 
Variables 
MET hours/week 
(n=47) 
Vigorous PA/week 
(n=46) 
VO2 peak 
(n=9) 
    
Category A  
    
SF-36 Physical Functioning .01 .53 .14 
SF-36 Role Personal .00 .51 .23 
SF-36 Bodily Pain -.10 .36 -.13 
SF-36 General Health -.05 .28 .23 
SF-36 Vitality -.06 .38 -.47 
SF-36 Social Functioning -.16 .26 .34 
SF-36 Role Emotion .06 .37 -.12 
SF-36 Mental Health -.08 .21 -.89 
SF-36 Physical Component Score -.06 .40 .40 
SF-36 Mental Component Score -.04 .26 -.58 
Health and Well-Being Rating .20 .46 .12 
Satisfaction with Life Scale -.06 .32 -.20 
BDI-II* .16 -.15 .55 
Note. * higher score is worse (i.e. more depression). 
 
 
Normative data 
When compared to normative data on the psychological variables, the CD sample had 
very slightly lower HRQL, as measured by the SF-36 and HWB ratings, similar levels of 
SWL and lower depression.   
The American College of Sports Medicine recommends that healthy adults, ages 
18 to 65 years participate in moderate intensity physical activity for at least 30 minutes, 5 
days per week or vigorous physical activity at least 20 minutes on 3 days per week 
(Haskell et al., 2007).  This recommendation equates to a MET expenditure of between 
450 to 750 MET minutes per week or 7.5 to 12.5 MET hours per week (Haskell et al., 
2007).  In 2007, the Centers for Disease Control and Prevention (Centers for Disease 
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Control and Prevention, 2007) reported that only 48.8% of men and women met the 
above recommendation.  The Phase 1 sample completed an average of 3.35 vigorous 
bouts of physical activity/week.  This sample also participated in a mean of 53 MET 
hours per week; however, this MET hour calculation included exercise, household 
activities, and gardening.   
Results: Phase 2 
Community-dwelling biopsy diagnosed adults (N=9), ages 41 to 71 yrs (M 
=55.33, SD=9.77), participated.  Age, biopsy status, gender, and GF diet adherence 
information is presented in Table 1.  The mean VO2 peak for the 7 female participants 
was 27.26 ml/kg/min (range 21.6-37.2), while the mean VO2 peak for the 2 male 
participants was 39.45 ml/kg/min (range 25.9-53.0). 
Relationships between VO2 peak and the psychological variable 
 VO2 peak was significantly related to SF-36 mental health (r=-.89, p=.001), 
indicating that as VO2 peak increases, mental health decreases.    
The correlations and effect sizes for the exploratory bivariate correlations between 
VO2 peak and all psychological variables are presented in Table 3   
VO2 peak was moderately positively correlated with the SF-36 aggregate physical 
component score (r=.40), and moderately negatively correlated with SF-36 vitality (r=-
.47), and the aggregate SF-36 mental component score (r= -.58).   
VO2 peak was not related to SWL.  VO2 peak was a moderate predictor of 
depression (r=.55), indicating that as VO2 peak increases, depression increases. 
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Normative data   
 When compared to normative data on aerobic fitness, the Phase 2 sample was 
very similar in terms of VO2 max for men (M=37.6, SD =3.8) and women (M=29.3, 
SD=3.6) in the moderate fitness category (N=3837 men; N=1110 women), as reported in 
the Aerobics Center Longitudinal Study (Stofan, DiPietro, Davis, Kohl III, & Blair, 
1998). 
Discussion 
The purpose of this pilot study was to determine if physical activity and aerobic 
fitness were related to HRQL, SWL and depression in CD patients.  In Phase 1, a self-
report physical activity scale was used to assess MET hours/week and number of 
vigorous bouts of physical activity/week.  In Phase 2, a VO2 max test was used to assess 
aerobic fitness.  Given the literature supporting a need to investigate HRQL and 
depression in CD patients, and the beneficial effects of physical activity in other disease 
state populations and in healthy populations, the primary purpose was to determine if 
physical activity could have similar beneficial effects in CD patients.  The study is 
exploratory in nature and limited in scope, but provides preliminary data on the 
relationships between physical activity and psychological outcome variables to guide 
continuing research.   
The findings in Phase 1 confirmed the prediction that vigorous bouts of physical 
activity/week were related to HRQL.  However, vigorous bouts of physical activity/week 
were not predictive of depression.  Further, MET hours per week were not significantly 
related to any of the mental health or HRQL variables.   
 65 
The findings in Phase 1 show that vigorous bouts of physical activity/week, but 
not MET hours, predicted the psychological variables.  It was hypothesized that both 
physical activity measures would predict HRQL and mental health; therefore, these 
mixed results were unexpected.  One likely explanation for these results is related to the 
method of measuring physical activity.  Physical activity was measured as the number of 
vigorous bouts of physical activity/week reported and MET hours/week calculated based 
upon the reported activities, durations, and intensities.  It is likely that participants are 
more able to accurately recall the number of vigorous bouts of physical activity/week 
performed than the details necessary to accurately calculate MET hours/week.  This 
conclusion is supported by the findings of several researchers.  Relative validity is greater 
when assessing vigorous activity than when assessing moderate activity in adults (Sallis 
& Saelens, 2000).  It has also been reported that lower reliability coefficients were found 
for household activities recalled from generic memory than for specific exercise bouts 
recalled from episodic memory (DiPietro, Caspersen, Ostfeld, & Nadel, 1993).   
Contextual cues may be present to help a responder identify exercise bouts; 
however, less structured daily activities, of light to moderate intensity, may be reported 
less due to lack of contextual cues (Matthews, 2002).  Thus, the significant relationships 
for vigorous bouts of physical activity/week, which measure only vigorous activity, 
might be indicative of less measurement error as compared to MET hours/week, which 
measures exercise, household, and garden activities with varying intensities.   
Depression and mood were also outcome variables in Phase 1 that were 
hypothesized to be positively associated with physical activity; however our data did not 
 66 
show vigorous bouts of physical activity/week or MET hours/week to be significantly 
related to these outcomes.  Further, it is unclear why vigorous bouts of physical 
activity/week and MET hours/week were generally not predictive of depression.  There is 
evidence that physical activity is most important for people who have increased 
depression.  For example, meta-analytic reviews have shown larger effects of physical 
activity on depression for moderately to severe clinically depressed populations as 
compared to mild to moderate depressed populations (Craft & Landers, 1998) and for 
those participants who were initially unhealthy, both physically and psychologically 
(North et al., 1990).  Given that this CD sample was less depressed than the general 
population, it might be that physical activity was not related to depression because this 
sample was not depressed. 
In Phase 2, moderate positive correlations were found for VO2 peak with the SF-
36 aggregate physical component score; however, other findings in Phase 2 indicated that 
VO2 peak was negatively associated with other psychological outcomes (i.e. SF-36 
mental, BDI-II), meaning that as VO2 peak increased, mental HRQL and depression 
worsened.  These negative findings were unexpected, but are likely due to the small 
sample which might have precluded the ability to observe significant relationships.   
In conclusion, although the results of this study were not consistently supportive 
of a beneficial relationship between physical activity and psychological outcomes in CD 
patients, there were some findings that suggest that future study is warranted.  In 
particular, in this sample of CD patients, who were not experiencing psychological 
distress relative to population norms, there was a consistent positive relationship between 
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vigorous bouts of physical activity/week and all of the psychological measures.  That is, 
CD patients who performed more vigorous bouts of physical activity/week reported 
better HRQL and better satisfaction with life than did those who participated in less 
vigorous bouts of physical activity/week.  These results were not corroborated by the 
METs data or by the VO2 peak data. However, the METs data is likely to be less reliable 
given the measurement issues associated with this data.  Further, the VO2 peak data came 
from only 9 participants suggesting that future research will be needed to explore the role 
of fitness in potential relationships between physical activity and psychological 
outcomes.   
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CHAPTER IV 
 
METHODS 
 
 
Participants 
A total of 47 community dwelling men and women between the ages of 24 to 70 
years with CD were recruited to participate in the study.   
CD patients were recruited from local CD support group chapters.  The following 
chapters in North Carolina (NC) were contacted: NC Piedmont Triad Gluten Intolerance 
Group in Winston Salem, NC, Triangle Gluten Intolerance Group in Durham, NC, 
Asheville Gluten Intolerance Group, in Ashville, NC, Celiac Support Group in Charlotte, 
NC.  Other chapters in Virginia, South Carolina, California, Florida, and Pennsylvania 
were contacted to ensure that there were enough participants.   
Further, newspaper advertisements (News and Record, Greensboro, NC), 
newsletter inserts (CD newsletters), and flyer postings were used.  Flyers were posted in 
local health food stores, such as Whole Foods, Earthfare, Trader Joe’s and Deep Roots 
Market.  Also, an advertisement for the study was posted on the Gluten Intolerance 
Group website (www.gluten.net), on the Celiac.com “Celiac Disease - Gluten Free” 
message board (www.celiac.com), on the Celiac Chicks website, 
(celiacchicks.typepad.com) and on craigslist (craigslist.org) in the volunteer section.  
Participants contacted the principle investigator via phone or email in response to the 
advertisement.  An introductory letter was then emailed or U.S. mailed to the 
participants.  See Figure 1 for a summary of the recruitment process. 
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Able to travel to the 
testing site; N=144
Inquiries regarding
study; N=346
RECRUITMENT
(Flyers, Internet)
Not able to travel to 
testing site; N=202
Scheduled for 
Testing; N=56
Not approved
N=15
PAR-Q’s & phone
Screening; N=126
Approved to 
Participate; N=111
Tested
N=47
Withdrew
N=46
Withdrew
N=9
Withdrew
N=18
 
 
Figure 1. Recruitment process 
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Characteristics of this CD sample 
The mean age of this sample was 49 years (SD= 12.54) and 72% of the 
participants were women.  The percent of female participants is similar to that of other 
studies (Ciacci et al., 1995; Green, 2005; Green et al., 2001) and the pilot study (see 
Table 5).  As with the pilot sample, data indicated that this CD sample also scored higher 
than population norms on physical activity levels (i.e. number of vigorous bouts per week 
and MET hours per week) and HRQL.  This sample also scored higher than population 
norms on most executive function tests.  Further, GF diet adherence in this sample was at 
100% for all participants.  Reasons for this above average HRQL, excellent diet 
adherence, and high levels of physical activity could be a result of the recruitment 
methods used in this study.  A majority of the participants in the sample were members of 
a local or national support group.  Thus, these CD patients appear to be using problem-
focused coping and therefore might have different characteristics than those who are not 
members of a support group. 
A summary of these normative comparisons is presented in Table 6; however, a 
more detailed description of the normative comparisons can be found in the results 
section. 
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Table 5 
Pilot Study and Dissertation Study Sample Characteristics 
 
 Sample 
 
Participation 
Pilot 
(N) 
Dissertation 
(N) 
N 47 47 
Male 10 13 
Female 37 34 
Biopsy/Endoscopy Diagnosis 42 39 
Yes to GF Diet Adherence Within Past 2-weeks 45 47 
     100% Adherence 30 43 
     90% Adherence 15 4 
     75% Adherence 2 0 
 
 
 
Table 6 
Summary of CD Sample Compared to Normative Values for Predictors and Criterion 
 
 
Variables 
Dissertation Sample  
Compared to Normative Group 
 
Vigorous Bouts 
 
Better than  
 
MET Hours 
 
Better than  
 
VO2 max 
 
Better than  
 
SF-36 
 
Better than 
 
CDQ 
 
Better than 
 
MMSE* 
 
Same or Slightly Better 
 
Trail Making Test* 
 
75% percentile 
 
Digits Backward 
 
Better than 
 
Verbal Fluency* 
 
Same or Slightly Worse 
 
The CLOX Test  
 
Better than 
Note.  * relationship changes slightly based on age grouping and/or education level 
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Inclusion and Exclusion Criteria 
The goal of the inclusion criteria was to include all CD patients who were willing 
and able to complete the study and who could safely complete a submaximal aerobic 
fitness test.  Participants were included or excluded based on their answers to the 
questions asked on the Physical Activity Readiness Questionnaire (PARQ).  Exclusion 
criteria included conditions that would preclude performance of the submaximal aerobic 
fitness test (including a risk assessment as identified on the PARQ), functional limitations 
(i.e., could not walk 1-mile), use of medications that would suppress blood pressure or 
heart rate during the submaximal test, severe symptomatic heart disease), the 
consumption of psychotropic drugs, and inability to speak or write English. 
Risk Assessment 
Risk was assessed based on information obtained in the PARQ.  According to 
Table 2-4, American College of Sports Medicine Risk Stratification Categories, 
participants were stratified into one of three risk categories.  Low risk was defined as men 
less than 45 years of age and women less than 55 years of age who were asymptomatic 
and met no more than one risk factor threshold from Table 2-2 (PARQ) (American 
College of Sports Medicine, 2006).  Those in this low risk category were immediately 
invited to participate.  Moderate risk was defined as men greater than or equal to 45 years 
and women greater than or equal to 55 years or those younger adults who met the 
threshold for two or more risk factors from Table 2-2 (American College of Sports 
Medicine, 2006).  Those in this moderate risk category needed physician approval prior 
to completing the study.  High risk was defined as individuals with one or more signs and 
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symptoms listed in Table 2-3 or known cardiovascular, pulmonary, or metabolic disease 
(American College of Sports Medicine, 2006) Those in this high risk category were 
excluded from the study. 
Materials 
Assessment of Potential Covariates   
Potential covariates that were available for inclusion as predictors in the 
regression model were: age (in years), gender (male, female), diet adherence rate 
perception (the subjects’ self-report measure of their perceived % GF diet adherence over 
the last 2 weeks), diagnosis type (biopsy, blood, other, none), age at diagnosis, general 
cognition (MMSE score), and degree of satisfaction with information provided by doctors 
(level of satisfaction on a 5 point scale; score for diagnosis doctor and current doctor).  
Scores for these variables can be found in Table 7. 
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Table 7 
Potential Covariates 
 
Covariate Measures  Scores/Variables 
 
Age 
  
In years (continuous variable) 
Gender 
 
 0 = female; 1 = male 
Diet Adherence Rate 
Perception 
 
 0 = 100%; 1=90%; 2=75%; 3=50%; 4=25%; 5=0%; 
Collapsed to 2 variables (0,1) 
Diagnosis Type  Biopsy/Endoscopy of small intestine = 0; Blood test = 
1; Dermatitis herpetiformis /Skin Biopsy = 2; Capsule 
Endoscopy = 3; Other = 4 
Collapsed to 2 variables (0. 1) 
 
Age at Diagnosis 
  
In months (continuous) 
 
General Cognition  Mini Mental State Exam score (continuous) 
Degree of Satisfaction with 
Information Provided by 
Doctors 
 2 scores (diagnosis doctor; current doctor) based on 
the following scale: Not at all (1); slightly (2); 
moderately (3); quite a bit (4); extremely (5); Dummy 
coded into 4 variables 
 
 
Diet adherence rate, age at diagnosis, and satisfaction with information provided 
by doctors were found to be influential in prior literature that assessed HRQL using both 
the SF-36 and Celiac Disease Questionnaire (CDQ) (Häuser, Gold, Stallmach, Caspary, 
& Stein, 2007) Age, gender, and general cognitive ability have been found to impact 
cognitive performance (Etnier & Landers, 1997; Etnier et al., 2006).  These variables 
were assessed at entry into the study through the general demographics and health 
questionnaire and the MMSE.   
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Assessment of Independent (Predictor) Variables 
Physical activity level.  The Aerobics Center Longitudinal Study Physical 
Activity Questionnaire measured self-reported level of physical activity(Kohl, Blair, 
Paffenbarger, Macera, & Kronenfeld, 1997).  Validity correlations for treadmill time with 
run workouts (r=.35) and treadmill time with frequency of sweating (r=.51) (N=374) 
were reported from the survey (Kohl et al., 1988).  Oliveria, Kohl, Trichopoulos III, and 
Blair (1996) reported correlation coefficients of r=.41 for maximal exercise treadmill 
time with weekly energy expenditure from physical activity for baseline physical activity, 
and r=.32 for follow-up physical activity (N=7570).  Based on the pilot study, additional 
questions were asked so that the PI could better assess the intensity of some of the 
exercises, as well as differentiate between types of exercise (i.e. walking on a treadmill 
versus walking outside; mountain biking versus road cycling).  These additional 
questions insured that MET values could be accurately calculated, from the Compendium 
of Physical Activities Tracking Guide (Ainsworth, 2002; Ainsworth et al., 2000), based 
on the participant responses in three areas: exercise, household activities, and 
lawn/gardening activities (see Table 8).  If MET hours per week could not be accurately 
calculated, due to confusing or incomplete data, then total minutes of exercise was 
calculated.  Number of vigorous bouts of physical activity per week were determined by 
the response to question #2 on the survey, “How many times a week do you engage in 
vigorous physical activity long enough to work up a sweat? ____(times per week)” (see 
Table 8).  This survey took 10-15 minutes to complete. 
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Functional fitness test.  The Timed “Up and Go” Test (TUG) (Podsiadlo & 
Richardson, 1991) was used to assess functional mobility.  While being timed, seated 
participants rose from a chair with arm rests, walked 3 meters as quickly as possible`, 
turned 180 degrees, returned to the chair, and sat down.  One practice trial was given.  
The participant was scored based on the average time it took to complete two real trials.  
Inter-rater reliability has been reported as 0.99, while intra-rater reliability is 0.99 
(Podsiadlo & Richardson, 1991).  Podsiadlo and Richardson (1991) tested validity by 
measuring the correlation between the TUG and the subjects’ balance (r=-.55), gait speed 
(r=-.55), and functional capacity (r=-.51).  The TUG score was the average of the two 
trials in minutes and seconds (see Table 8).  This test took 5 minutes to complete. 
Aerobic fitness (submaximal exercise test). Peak oxygen consumption (VO2peak) 
during performance of a graded exercise test is considered the “gold standard” measure 
of aerobic fitness (Vanhees et al., 2005).  VO2 max is reached if the participant 
demonstrates a plateau in VO2 as the work rate continues to increase; however, usually 
less than 50% of the subjects tested demonstrate that plateau (Davis, 2006).  Therefore, 
the participant is said to have reached VO2 peak.  However, since conducting a VO2 max 
test in the laboratory is costly and time consuming, and would have limited the subject 
pool geographically, participants were tested in the field, using a submaximal test of 
aerobic performance.  VO2 max was then estimated based on the results of the test.  The 
Rockport One-Mile Fitness Walking Test has been used and shown to be valid and 
reliable in both fit and unfit populations across a wide age range and both genders (Kline 
et al., 1987) Therefore, aerobic fitness was determined with The Rockport One-Mile 
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Fitness Walking Test.  Kline et al. (1987) tested 343 healthy subjects, ages 30 to 69 years, 
who each performed the 1-mile timed walk twice.  Validity for heart rate (r=.93) and time 
(r=.98) were reported, as was reliability for heart rate (SEE=7.6 bpm) and time (SEE = 
0.26 min).   
Prior to the 1-mile walk, body weight, age and gender were recorded.  Participants 
were asked to walk one mile (1,609 m) as fast as possible, without running or jogging.  
This test was conducted outside on a flat level surface or inside on a track.  Each 
participant was secured with a Polar heart rate monitor and peak heart rate was recorded 
immediately after completion of the walk.  The PI used a digital stop watch to measure 
the time of the walk to the nearest minute and hundredths of a minute.  Participants 
continued to walk to cool down for up to 5 minutes.  Participants were tested 
individually.  Lastly, the PI was only allowed to give encouragement every 2 minutes or 
once every 400 meters (if on a track) by saying one or all of the following: “Good job.  
Keep up the good work.  Almost there.  Keep working hard.”  This test took 12-25 
minutes to complete. 
VO2 max in ml/kg/min was estimated, as presented in Table 8, using the inputs 
obtained (body weight (lbs), age (yr), gender (male = 1, female = 0), time for the walk in 
minutes and hundredths of a minute, and HR peak), as follows:  VO2 max (ml/kg/min) = 
132.853 - (0.0769 x weight) - (0.3877 x age) + (6.315 x gender) - (3.2649 x time) - 
(0.1565 x HR peak) (Kline et al., 1987).  
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Table 8 
Predictor Variable Scores Used in Statistical Analyses 
 
Instrument  Description  Scores 
 
   
Calculated METS 
 
The Aerobics Center 
Longitudinal Study 
Physical Activity 
Questionnaire  (modified) 
 
 
Self-reported level of 
physical activity  Number of vigorous bouts 
of physical activity 
 
The Timed “Up and Go” 
Test 
  
Functional mobility 
  
Average of 2 Timed Trials 
 
The Rockport One-Mile 
Fitness Walking Test 
  
Walked 1-mile as quickly 
as possible 
  
Estimated VO2 max from 
recorded time to 
completion, gender, body 
weight, age, and peak HR 
at end of walk 
 
 
Assessment of Dependent Variables 
Mini mental state examination (MMSE).  The MMSE, an 11-question test, 
measured cognitive and mental status in adults by assessing orientation, registration, 
attention and calculation, recall, and language.  It took 10 minutes to administer.  The 
maximum score was 30 and a score of 24 or lower was considered indicative of cognitive 
impairment (Kurlowicz & Wallace, 1999).  If greater than 5 subjects scored a 24 or lower 
on the MMSE, then they would be analyzed separately.  This did not occur, as no 
subjects scored below a 26.  This test took 5 minutes to complete.  One score was 
calculated and used in the analyses. 
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General demographic and health status questionnaire (GDHSQ).  This 
questionnaire assessed: doctor/patient and nutritionist/patient satisfaction, as measured 
with a 5-point Likert scale, demographics (age, gender, and education level), contact 
information, medications, diet adherence rate perception, CD diagnosis type, and age at 
diagnosis.  This questionnaire took 10-20 minutes to complete.  The questionnaire 
assessed the covariates of interest, and some additional demographic areas for descriptive 
reporting.   
Trail making test (A&B).  The primary task, Trail Making, is the most widely 
used task to assess divided attention and cognitive flexibility (Lezak et al., 2004).  
Further, Trail Making is responsive to detecting dementia and brain injury.  The Trail 
Making Test is currently part of the Halstead Battery and it measures attention, speed and 
mental flexibility (Strauss, Sherman, & Spreen, 2006).  The test has two parts, part A, 
which requires the participant to connect 25 encircled numbers in the correct order, and 
part B, which requires connecting 25 encircled numbers and letters in alternating order.  
Reliability coefficients have been reported between 0.46 and 0.79 for Part A and between 
0.44 and 0.89 for Part B (Strauss et al., 2006).  This test took 5 minutes to complete.  
Time in seconds that it took complete Part A and Part B were recorded.  Next a ratio was 
calculated by dividing the Part B time in seconds by the Part A time in seconds.  Finally, 
the difference score was calculated by subtracting Part A time in seconds from Part B 
time in seconds.  Two scores (Trails A, Trails B), as presented in Table 9, were 
calculated. 
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Digits backward (WIS-A, WMS).  Digits backward measures span of immediate 
verbal recall and is included in the Wechsler batteries’ intelligence and memory scales.  
The list of digits is read to the participant and upon hearing the digits, the participant 
must repeat the digits back to the investigator in reverse order.  There are seven pairs of 
randomly ordered digit sequences.  The test measures auditory attention, short-term 
retention capacity, and working memory.  The test is sensitive to left hemisphere damage, 
visual field defects, diffuse damage, and lesions (Lezak et al., 2004).  This test took 5 
minutes to complete.  The score was the total number of correctly repeated digit lists.  
(see Table 9). 
Verbal Fluency.  The verbal fluency test consists of three, one-minute word 
naming trials and usually uses the letters, F-A-S.  The following instructions were given: 
“I will say a letter of the alphabet.  Then I want you to give me as many words that begin 
with that letter as quickly as you can.  For example, if I say “b” you might give me “bad, 
battle, bed…”  I do not want you to use words that are proper names such as “Boston, 
Bob, or Buick.”  Also, do not use the same word with different endings such as “eat” and 
“eating.”  Any questions? (pause).  Begin when I say the letter.  The first letter is F.  Go 
ahead.”  Slang words, foreign words, proper names, wrong words, nonwords and 
repetitions are not included in the total.  A stop watch was used.  Using letters F-A-S, 
internal reliability was reported to be r=.83.  The letter “L” was used as an alternate.  This 
test took 7 minutes to complete.  Scoring for verbal fluency was the sum of the 
acceptable words produced during the trials. 
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The clock drawing test.  The clock drawing test is able to detect dementia and 
executive function impairment.  There are many different versions and administration 
systems of the Clock Drawing test.  The version that was used in this study was the 
CLOX test developed by Royall, Cordes, and Polk (1998).  The CLOX test has two parts, 
the CLOX1 and CLOX2.  The CLOX1 detects executive function and uses the following 
directions: ‘Draw me a clock that says 1:45.  Set the hands and numbers on the face so 
that a child could read them.”  CLOX2 requires the subject to copy a clock that the 
investigator drew after the subject has observed it.  Five minutes is required to complete 
the two clock drawing tasks.  Two scores are obtained, CLOX1 and CLOX2.  Reliability 
(internal consistency) in elderly subjects (45 years old and well and 45 years old and with 
probable Alzheimer’s Disease) was found to be r=.82, while between rater reliability was 
also high for both the CLOX1 (r=.84) and CLOX2 (r=.93) (Royall et al., 1998).  The 
CLOX1 scores and the EXIT25 (executive test) and Mini Mental State Exam were highly 
correlated (partial r
2
=.71) after adjusting for age and education and the Mini Mental State 
Exam and CLOX2 were highly correlated (partial r
2
 =.74) (Royall et al., 1998).  ClOX 1 
and CLOX 2 scores were calculated and used in the statistical analyses (see Table 9). 
This test took 3-5 minutes to complete.   
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Table 9 
Executive Function Criterion Variable Scores Used in Statistical Analyses 
 
Instrument Description   Scores 
 
 
  Trails A score 
 
Trail Making Test 
(A&B) 
 
Measures attention, speed and 
mental flexibility.   Trails B score 
 
Digits Backward  
 
Measures span of immediate verbal 
recall, auditory attention, short-term 
retention capacity, and working 
memory. 
 
  Total score  
 
Verbal Fluency 
 
Consists of three, one-minute word 
naming trials that use the letters, F-
A-S.  A sensitive indicator of brain 
dysfunction.  Sensitive to frontal 
lobe damage. 
 
  Total score for 3 letters 
 
The CLOX Test  
 
Detects dementia and executive 
function impairment. 
 
  CLOX 1, CLOX 2 (copy task) 
 
 
 
Medical outcomes study (MOS) 36-item short-form health survey.  The 36-item 
Health Survey is part of the Medical Outcomes Study (MOS).  A modified version, the 
MOS 36-item Short-form Health Survey (SF-36) (Ware & Sherbourne, 1992) was used to 
measure perceived level of functioning.  The SF-36 measures eight health concepts and 
general health perceptions: physical functioning, bodily pain, role limitations due to 
physical health problems, role limitations due to personal or emotional problems, general 
mental health, social functioning, energy/fatigue, and general health perceptions (Hays, 
Sherbourne, & Mazel, 1993).  The SF-36 contains eight subscales, one Reported Health 
Transition score, and two aggregate scores.  The eight subscales, which are presented in 
Figure 2, are as follows: Physical Functioning (SF-36 PF), Role-Physical (SF-36 RP), 
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Bodily Pain (SF-36 BP), General Health (SF-36 GH), Vitality (SF-36 VT), Social 
Functioning (SF-36 SF), Role-Emotional (SF-36 RE), and Mental Health (SF-36 MH).  
The two aggregate scores are the SF-36 Physical Component Score (SF-36 PCS) and SF-
36 Mental Component Score (SF-36 MCS) (see Table 10).   
According to Lox et al. (2006), the SF-36 has been used to assess the effect of 
exercise on HRQL in the frail elderly (Schechtman & Ory, 2001), cardiac rehabilitation 
patients (Milani, Lavie, & Cassidy, 1996), women with breast cancer (Segal et al., 2001), 
and people with Type 2 diabetes (Kirk et al., 2001).  This test took 10 minutes to 
complete.  The SF-36 Physical Component Score and SF-36 Mental Component Score 
were used in the analyses. 
 
 
Mental Health
SF-36
Mental Health
SF-36
Physical Health
Physical Functioning
Role Physical Body Pain
General Health
Vitality
Social Functioning Role Emotional  
Figure 2. SF-36 diagram 
 
 
 
Celiac disease questionnaire (CDQ).  This is a CD-specific measure of HRQL, 
which has four scales: GI symptoms, emotional well-being, social restrictions and 
disease-related worries.  The CDQ has four scales, as presented in Figure 3, which are: 
Emotion, Social, Worries, and Gastrointestinal.  It takes 10 to 20 minutes to complete.  
Each scale has seven items and the patient responds using a 7-point Likert scale.  A high 
score is indicative of good HRQL.  The CDQ was developed and validated by Häuser et 
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al. (2007).  The internal consistently (Cronbach alpha) and retest reliability (Pearson 
correlation) for each of the subscales have been reported by Häuser et al. (2007). : 
emotion (α=0.91; r=0.52), social (α=0.81; r=0.55), worries (α=0.81; r=0.89), 
gastrointestinal (α=0.80; r=0.45), and total score (r=0.57).  This test took 10 minutes to 
complete.  Four subscale scores, as well as a total score (CDQ total) were calculated, but 
the total score was used first during the statistical analyses (see Table 10). 
 
Emotion Social Worries
Celiac Disease Questionnaire
GI
 
 
Figure 3. Celiac Disease Questionnaire diagram 
 
 
 
Table 10 
HRQL Criterion Variable Scores Used in Statistical Analyses 
 
Instrument Description   Scores 
 
   
  Physical Component Score 
 
SF-36 
 
HRQL (physical functioning, role-
physical, bodily pain, general health, 
vitality, social functioning, role-
emotional, mental health) 
  Mental Component Score 
 
Celiac Disease 
Questionnaire 
 
Celiac Disease specific HRQL 
(emotion, social, worries, 
gastrointestinal) 
   
  CDQ Total 
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Experimental Procedures 
 
The introductory letter outlined and introduced the research study and explained 
the volunteer parameters, consent, and confidentiality.  It was emailed or U.S. mailed to 
the participants.  This letter asked the participants to email or call if interested in 
participating in the study.  The introductory letter also explained the inclusion and 
exclusion criteria as outlined below.  Eligibility was assessed over the telephone by using 
the PARQ.  Eligible participants were scheduled for testing.  Upon arrival at the testing 
site, the PI introduced herself and explained the purpose of the study, including the 
surveys, physical activity testing, and the cognitive testing.  The participant was then 
asked to read and sign an informed consent.  All human studies were approved by the 
Institutional Review Board at the University and therefore have performed in accordance 
with the ethical standards laid down in the 1964 Declaration of Helsinki.   
The participant completed the MMSE.  This took approximately 5 minutes.  After 
reading the instructions, the participant completed and answered questions in the General 
Demographic and Health Status Questionnaire.  This took about 10-20 minutes to 
complete.  Following completion of that questionnaire, the participant completed the 
cognitive testing, which consisted of the Trail Making Test (A&B), Digits Backward 
verbal fluency, and the CLOX test.  The cognitive testing took approximately 15-20 
minutes.  After the cognitive testing was completed, they were directed to complete the 
36-Item Short Form Health Survey (SF-36), the Celiac Disease Questionnaire, and the 
Aerobics Center Longitudinal Study Physical Activity Questionnaire.  The final three 
questionnaires took approximately 30-45 minutes to complete. 
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 After the questionnaires were completed, participants completed the TUG, a 
measure of functional fitness, and the Rockport 1-Mile Fitness Walking Test, a 
submaximal test of aerobic fitness.  These took approximately 5 minutes, and 12-25 
minutes to complete, respectively.  Debriefing about the study occurred after the 
Rockport 1-Mile Fitness Walking Test.  See Figure 4 for a pictorial description of the 
experimental procedures. 
 
Advertising & Recruiting 
Screening
Consent
Complete General Surveys
Complete PA Survey
Complete HRQL Surveys
Complete Cognitive Tests
Complete Functional Fitness Test
Complete Aerobic Fitness Test
Break
Session Completion & Debriefing
 
Figure 4. Flow of procedures 
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Power Analyses 
Health-Related Quality of Life Variables 
To provide sufficient statistical power for the HRQL variables, data needed to be 
collected on a minimum of 15 subjects.  This sample size was determined based upon a 
power of 80% and the data from the pilot study.  The data from the pilot study were used 
to inform Table 11.  There are columns for both four and eight prior covariates.  The 
covariates that were included in the pilot study were gender, age (years), biopsy (yes/no), 
and gluten free diet adherence perception (% of the time). However, subject size for the 
current study was estimated using eight covariates since additional potentially relevant 
covariates have been identified since conducting the pilot study.  The predictor variables 
used in the pilot study and used in the proposed study are VO2 peak, and a principal 
components factor score to reflect physical activity (combined METs per week and 
number of vigorous bouts per week).  These are identified as the “number of covariates to 
add, B” in the table.  The dependent variables for the pilot study and for the proposed 
study are the SF-36 Physical Component Score (PCS) and the SF-36 Mental Component 
Score (MCS) and these represent the columns in Table 11.  The RA
2
 values of 0.338 and 
0.568 and the “Increase in R
2
” values of 0.398 and 0.322 were taken from the pilot study 
and used as estimates of the predicted explained variance for the proposed study.  Given 
this data, the predicted necessary sample size to insure sufficient statistical power is 
provided in the final row of the table.  Therefore, 11-15 subjects were needed with a 
power of 80% to detect an increase in R
2 
between .32 and .40 for HRQL.   
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Table 11 
Same Size Needed with 80% Power to Detect an Increase in R2 between .32 and .40  
 
HRQL  
Power Analysis Variables PCS MCS 
Number of prior covariates 4 8 4 8 
Alpha 0.05 0.05 0.05 0.05 
Correlation, RA
2
, for A covariates 0.338 0.338 0.568 0.568 
Number of covariates to add, B 2 2 2 2 
Increase in R
2
 = RAB
2
- RA
2
 0.398 0.398 0.322 0.322 
Power (%) 80 80 80 80 
N 13 15 11 14 
Note.  PCS=SF-36 Physical Component Summary Score; MCS=SF-36 Mental 
Component Summary Score; N = number of subjects needed; RA
2 
= correlation of 
covariates 
 
 
Cognitive Performance Variables 
Although analyses using the cognitive variables were secondary, a power analysis 
was conducted to identify the range of subjects needed.  No pilot data was available for 
the cognitive performance variables assessed; therefore, the number of subjects needed to 
insure sufficient statistical power (.80) to detect a range of possible relationships was 
identified.  A range of potential increases in R
2
 that might be detected was identified 
(vertical).  A range of correlations (R
2
) for the covariates age and gender are also listed 
(horizontal).  The number of subjects needed is listed in Table 12.  Approximately 38-78 
subjects were needed to have enough power to detect an effect (.08 to .10) of aerobic 
fitness on cognitive performance given a prior correlation of the covariates (.338 to .568).  
The prior correlation of the covariates was derived from pilot data (study is mentioned 
above) on a Celiac Disease sample that assessed HRQL.  The effect of aerobic fitness on 
cognitive performance is 0.08-0.10 and this is based on data obtained from Etnier et al.’s 
(2006) meta-analysis which showed that r=.29; r
2 
= .0841. Thus, given a sample size 
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between 38 and 78, the analyses would have sufficient statistical power to detect an effect 
size of .08-.10 given that covariates account for 30-55% of the variance.  Given that this 
was a secondary analysis and that the effects when both aerobic fitness and physical 
activity are accounted for could be expected to be slightly larger, a sample size of 40 
subjects is proposed (situations for which this will result in sufficient statistical power are 
identified in blue font). 
 
Table 12  
Number of Subjects (N) Needed Based on the Explained Variance Due to Covariates and 
Possible Increases in Explained Variance as a Function of the Current Predictors 
(Physical Activity and Aerobic Fitness)  
 
RA
2
 Increase 
in RA
2
 .10 .15 .20 .25 .30 .35 .40 .45. .50 .55 
.05 167 158 148 139 129 119 110 100 90 81 
.08 102 96 90 84 78 72 66 60 54 48 
.10 81 76 71 66 62 57 52 47 43 38 
.12 66 62 58 54 50 46 43 39 35 31 
.14 56 53 49 46 43 39 36 32 29 26 
.16 48 46 43 40 37 34 31 28 25 22 
.18 43 40 37 35 32 29 27 24 22 19 
.20 38 35 33 31 28 26 24 22 19 17 
 
Note.  Power = 80%; Alpha = 0.05; Number of prior covariates is four; Number of 
covariates to add is two; RA
2
 = correlation of covariates 
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Statistical Analyses 
Scores for physical activity, aerobic fitness, TUG, HRQL, and Executive Function 
were compared to normative values and/or mean values from similar populations.  All 
statistical analyses were conducted using SPSS 14.0 (SPSS Incorporated, Chicago, IL).  
Covariates 
Seven of the eight (age, gender, diet adherence rate perception, diagnosis type, 
age at diagnosis, general cognition, and degree of satisfaction with information provided 
by doctor at diagnosis) hypothesized potential covariates were considered for inclusion in 
the analyses when the predictor variables (MET hours per week, number of bouts of 
vigorous physical activity, estimated VO2 max) were significant.  Bivariate correlations 
were used to determine if they would be included.   
Satisfaction with information provided by current GI doctor was not available for 
inclusion, since only 27 of the 47 subjects were actually seeing a GI doctor for CD.  
Covariates that were categorical (and that were not binary) were dummy coded.  The 
covariate “diagnosis type” was collapsed from 4 types to 2 types (0=any type of biopsy, 
1=blood test or other).   
Bivariate correlations were conducted with the seven covariates and each of the 
dependent variables.  If a Pearson correlation was significant (p<.05), then that covariate 
was considered for inclusion.  The covariates were included in both a canonical 
correlation model and a multivariate multiple regression as predictors, and the canonical 
correlation (from the canonical correlation model) and p values (from the multivariate 
multiple regression) were judged to determine if the covariate would stay in the model or 
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be removed.  Covariates were examined individually and if a particular covariate did not 
contribute to the model, based on a high p value, it was removed and the analysis was 
repeated.  However, if removal of the covariate resulted in a large decrease in the 
canonical correlation, then the covariate was added back into the model.   
Analyses of Aims 
Exploratory bivariate correlations were conducted for the HRQL variables and the 
executive function variables with physical activity, aerobic fitness, and TUG.   
Canonical correlations were used for all dependent variables (See Table 13).  
Canonical correlation is a subclass of multivariate regression (Green, Halbert, & 
Robinson, 1966).  This method is used when a researcher is interested in relationships 
between sets of variables (Green et al., 1966; Levine, 1977).  The canonical correlation 
allows for a relationship to be established between two canonical or latent variables. 
These variables represent a set of independent variables and a set of dependent variables.  
Linear combinations of the two sets of latent variables are created and these will have 
maximum correlation with one another (see Figure 5).  As a result, a canonical 
correlation, represented by Rc, is derived.  The Rc is interpreted the same as a Pearson’s r.  
Standardized coefficients (or standardized canonical weights) for each variable are also 
provided.  These weights are sometimes useful in determining the relative importance of 
each variable in the relationship by looking at the sign and magnitude of the standardized 
weight (Alpert & Peterson, 1972).  However, this procedure is to be taken with caution in 
that it is difficult to determine the relative importance for a couple of reasons.  For 
example, a small weight could mean one of two things: that the variable is unimportant in 
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the relationship, or that the variable is so highly correlated with another variable that its 
weight has been reduced.  Second, interpretation is difficult because all of the variable are 
correlated with one another simultaneously (Alpert & Peterson, 1972).  That is, an 
individual variable’s importance is hard to determine given that the canonical correlation 
is derived from the optimal linear combination of those variables, while accounting for 
the inner correlation among those variables.  Therefore, removing or adding any variables 
to the set changes the dynamics of the relationship.  Therefore, due to the complex nature 
of these interpretations, the importance of the standardized canonical weights associated 
with each individual variable was not identified.   
 
Table 13 
Aims and Components of Canonical Composites 
 
Aim Predictors Criterion Components of the Criterion 
 
 
#1 (Primary) 
 
PA and AF 
 
HRQL 
  
   SF-36 PCS, SF-36 MCS 
   Celiac Disease Questionnaire Total 
 
#2 (Secondary) 
 
PA and AF 
 
Executive 
Function 
  
   Trail Making A, Trail Making B,  
   Digit  Span, Verbal Fluency,  
   ClOX 1,  ClOX 2 
 
Exploratory 
 
Functional 
Fitness 
 
HRQL & 
Executive 
Function 
  
   Same as #1 and #2 above 
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X2
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X* Y*
Y1
Y3
Y2
Rc
 
 
Figure 5.  Canonical correlation  
 
A canonical composite of the total HRQL scores (CDQ total, SF-36 PCS, and SF-
36 MCS) was correlated separately with MET hours per week, number of vigorous bouts 
of physical activity per week, estimated VO2 max, and TUG.  See Figure 6 for an 
example of the canonical correlation for the HRQL composite with vigorous bouts of 
physical activity per week. 
 
Vigorous 
Bouts
X* Y*
PCS
CDQ
MCS
Rc
 
Figure 6.  Canonical correlation for HRQL with Vigorous Bouts 
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Canonical correlations were used for all executive function dependent variables 
(Trails A, Trails B, Digits Backwards, Verbal Fluency, CLOX 1, CLOX 2).  Executive 
function was correlated separately with MET hours per week, number of vigorous bouts 
of physical activity per week, estimated VO2 max and TUG.  See Figure 7 for an example 
of the canonical correlation for the executive function composite with vigorous bouts of 
physical activity per week. 
 
CLOX1
Vigorous 
Bouts
X* Y*
Trails A
DigBkw
Rc
Trails B
VerbalFl
CLOX2
 
 
Figure 7.  Canonical correlation for Executive Function with Vigorous Bouts 
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CHAPTER V 
RESULTS 
 
 
Descriptive Information and Statistics 
Descriptive information for this CD sample is presented in Table 14.  Means and 
standard deviations for all variables are presented in Table 15.  Descriptive information 
for questions that assessed doctor and nutritionist satisfaction are presented in Table 16. 
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Table 14  
Descriptive Statistics for the CD Sample 
 
Participation  N 
N  47 
Female (n)  34 
Percent (%) Female  72.34% 
Mean Score on Mini Mental State Exam (MMSE) (SD)  29 (4) 
Diagnosis Type   
Biopsy / Endoscopy of Small Intestine (n)  37 
Dermatitis Herpetiformis (n)  1 
Capsule Endoscopy (n)  1 
Blood Test (n)  7 
Other (n)  1 
Yes to GF Diet Adherence Within Past 2-weeks (n)  47 
100% Adherence (n)  43 
90% Adherence (n)  4 
 
Measure of Variable 
  
Mean (SD) 
Mean (SD) Age   49 (12.54) 
Mean (SD) Age (months) at Diagnosis  507.3 (163.83) 
Mean (SD) Time (months) Since Diagnosis to Research Study  89.79 (99.69) 
Mean (SD) Time (months) Adhering to the GF Diet  87.3 (100.27) 
Mean (SD) Bouts of Physical Activity / Week  3.36 (2.75) 
Mean  (SD) MET Hours / Week  61.15 (40.39) 
Mean (SD) VO2 max (ml/kg/min)  34.20 (8.0) 
Mean (SD) VO2 max (ml/kg/min) - Males  40.45 (5.91) 
Mean (SD) VO2 max (ml/kg/min) - Females  31.82 (7.44) 
Mean (SD) TUG (minutes)  4.71 (.94) 
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Table 15  
Descriptive Statistics for Physical Activity, Aerobic Fitness, Functional Fitness, HRQL, 
and Executive Function Variables (N=47) 
 
Variable Mean SD 
 
Number of Vigorous Bouts of PA/week 
 
3.36 
 
2.75 
Number of MET hours/week 61.15 40.39 
Estimated VO2 max (ml/kg/min) 34.20 8.00 
Timed Up and Go test
a 
(seconds) 4.71 .94 
CDQ – Emotion 37.19 5.49 
CDQ – Social 45.06 4.16 
CDQ – Worries 41.74 6.04 
CDQ – Gastrointestinal 41.38 5.36 
CDQ – Total Score 165.38 15.72 
SF-36 Physical Functioning 53.99 4.23 
SF-36 Role Personal 52.63 6.39 
SF-36 Bodily Pain 49.44 6.11 
SF-36 General Health 50.36 9.17 
SF-36 Vitality 52.69 8.22 
SF-36 Social Functioning 53.02 6.17 
SF-36 Role Emotion 52.90 5.20 
SF-36 Mental Health 53.42 6.16 
SF-36 Physical Component Score 51.27 5.49 
SF-36 Mental Component Score 53.17 5.66 
Trails A
a 
(seconds) 25.48 9.35 
Trails B
a 
(seconds) 55.79 20.20 
Trails B / Trails A ratio score 2.28 0.63 
Trails B – Trails A difference score 30.31 14.41 
Digits Backwards 7.81 2.22 
Verbal Fluency 43.26 10.83 
CLOX 1 13.47 0.99 
CLOX 2 14.64 0.64 
Note.  
a
 lower score indicates better performance 
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Table 16 
Information about Doctor/Nutritionist Consultations and Satisfaction with 
Doctors/Nutritionist (N=47) 
 
Variables n 
 
Satisfaction with information provided by doctor at diagnosis 
 
Not at all (1) 6 
Slightly (2) 9 
Moderately (3) 12 
Quite a bit (4) 11 
Extremely (5) 9 
Number of CD patients currently seeing a GI doctor for CD 27 
Satisfaction with information provided by current GI doctor  
Not at all (1) 1 
Slightly (2) 6 
Moderately (3) 4 
Quite a bit (4) 6 
Extremely (5) 10 
Number of CD patients who were referred to a nutritionist at diagnosis 26 
Number that attended a consultation with a nutritionist at diagnosis, if 
referred 
19 
Satisfaction with information provided by the nutritionist at diagnosis, if 
referred and if attended consultation 
 
              Not at all (1) 4 
              Slightly (2) 5 
             Moderately (3) 3 
             Quite a bit (4) 7 
             Extremely (5) 1 
 
 
 
Celiac Disease sample compared to normative values for dependent variable measures 
 The CD sample had a mean age of 49 years; therefore, their scores for SF-36 PCS 
and SF-36 MCS were compared to the norms for the U.S. population, males and females, 
ages 45-54 (N=1561) (Ware, Kosinski, & Dewey, 2000).  The CD sample scored higher, 
indicating better quality of life, than the normative sample on both SF-36 PCS and SF-36 
MCS.  The scores obtained from the CD sample for the CDQ were compared to subjects 
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(N=1000), also with CD, who were used to validate the CDQ questionnaire (Hauser et al., 
2007).  Our CD sample scored higher on all 4 subscales of the CDQ and the total CDQ 
than the normative group.  See Table 17 for a comparison of the CD sample to normative 
values for the SF-36 and CDQ. 
 
Table 17 
CD Sample Compared for Normative Values for the SF-36 and CDQ 
 
 Dissertation  
Sample 
Normative  
Sample 
HRQL  
Variables 
 
Mean (SD) 
 
 
Mean (SD) 
  
SF-36 PCS 
 
SF-36 MCS 
 
CDQ Total 
 
51.27 (5.49) 
 
53.17 (5.66) 
 
165.38 (15.72) 
 
49.46 (10.22) 
 
49.92 (10.22) 
 
151.1 (25.2) 
 
 
 
 The CD sample also has scores that were similar to normative values for the 
MMSE group with similar ages and years of education (see Table, 18).  When compared 
to the verbal fluency normative group with the same level of education, the CD sample 
performed slightly better (see Table 19). 
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Table 18 
CD Sample Compared for Normative Values for the MMSE 
 
    Dissertation  
  Sample 
    Normative  
    Sample 1* 
       Normative  
         Sample 2** 
   Normative  
       Sample 3*** 
Variable  
 
 
Mean 
 
SD 
 
Mean 
 
SD 
 
Mean 
 
SD 
 
Mean 
 
SD 
 
MMSE 
 
29 
 
4 
 
29 
 
1.6 
 
28 
 
1.9 
 
26 
 
2.5 
Note.  *45-49 year olds with college experience normative group; **45-49 year olds with 
a high school diploma; ***45-49 year olds with five to eight years of education; Crum, 
Anthony, Bassett and Folstein (1993) 
 
 
Table 19 
CD Sample Compared for Normative Values for Verbal Fluency 
 
 
 
Dissertation 
Sample 
Normative  
Group 1* 
Normative 
Group 2** 
 
Executive Function 
Variable 
 
Mean (SD) 
 
Mean (SD) 
 
Mean (SD) 
 
Verbal Fluency 
 
43.26 (10.83) 
 
40.5 (10.7) 
 
44.7 (11.2) 
Note.  *the normative group (N=268), with 9-12 years of education * the normative group 
(N=242) with 13-20 years of education Tombaugh, Kozak, and Rees (1999) 
 
The CD sample was considered to be in the 75
th
 percentile when compared to 
normative values, in the 45-54 age group, for Trails Making A and Trails Making B 
(Tombaugh, 2004).  A higher score is indicative of worse performance. 
On the Digit Span Backwards tests, the CD sample performed better than a mixed 
clinical sample (N=44) (see Table 20).  The CD sample scored better than both the young 
adult controls (N=62) and independent living retires (N=45) on both the CLOX1 and 
CLOX2 (Royall et al., 1998). 
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Table 20 
CD Sample Compared for Normative Values for Digit Span Backwards 
 
 
 
Dissertation  
Sample 
Normative  
Sample* 
 
Executive Function Variable 
 
Mean (SD) 
 
 
Mean (SD) 
  
Digit Span Backwards 
 
7.81 (2.22) 
 
6.02 (1.73) 
Note.  *Data from Wilde and Strauss (2002) 
 
 
Celiac Disease sample compared to normative values for independent variable measures. 
This CD sample completed more vigorous bouts of physical activity/week and 
participated in more MET hours of physical activity per week than the normative 
comparison groups (see Table 21). 
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Table 21 
CD Dissertation Sample’s Physical Activity Levels and Participation Compared to ACSM 
Physical Activity Recommendations 
 
 Dissertation  
Sample 
Physical Activity 
Recommendation (ACSM) 
 
Physical Activity 
Measure 
Mean (SD) % who meet 
Recommendation 
# 
Minutes/METs 
% who meet 
Recommendation 
 
Vigorous bouts of 
physical 
activity/week  
 
3.36 (2.75) 
 
59.6% 
 
20 minutes on 3 
days/week* 
 
48.8%** 
 
MET hours/week 
 
61.15 (40.39) 
 
100% 
 
7.5 to 12.5 MET 
hours/week* 
 
48.8%** 
Note.  *Haskell et al. (2007); **CDC U.S. Physical Activity Statistics 2007, Centers of Disease 
Control and Prevention (2007) http://apps.nccd.cdc.gov/PASurveillance/StateSumResultV.asp 
 
When compared to normative data on aerobic fitness, this CD sample of men and 
women was higher than the mean VO2 max found for both men and women in the 
moderate fitness category (N=3837 men; N=1110 women) in the Aerobics Center 
Longitudinal Study (Stofan, DiPietro, Davis, Kohl, & Blair, 1998) (see Table 22).   
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Table 22 
CD Dissertation Sample’s VO2 max compared to moderate fitness category in the 
Aerobics Center Longitudinal Study 
 
 
 
Dissertation 
Sample 
Normative 
Group* 
 
Aerobic Fitness Variable 
 
Mean (SD) 
 
Mean (SD) 
 
VO2 max  - Men 
 
40.45 (5.91) 
 
37.6 (3.8) 
VO2 max  - Women 31.82 (3.8) 29.3 (3.6) 
Note.  *Aerobics Center Longitudinal Study (Stofan, DiPietro, Davis, Kohl, & Blair, 
1998)  
 
Finally, the CD sample’s score (M=4.71, SD=.94) on the TUG test was lower 
(faster score) than the score obtained from ten normal controls with a mean age of 75 
years (M=8.5) and 60 elderly patients with a mean age of 79.5 years (time ranged 10 to 
240 seconds) (Podsiadlo & Richardson, 1991).  Since the TUG is used mainly in elderly 
patients, we were unable to find normative values for younger to mid-age adults. 
Bivariate Correlations Among the Predictor Variables 
Bivariate correlations showed that vigorous bouts of physical activity/week was 
significantly moderately correlated with MET hours/week (r = .46; p=0.001).  None of 
the other relationships between MET hours/week, VO2 max, or physical activity/week 
were statistically significant.    
Bivariate correlations showed that the TUG was positively correlated with 
estimated VO2 max (r = -.59; p<0.001) and number of vigorous bouts of physical 
activity/week (r = -.33; p=0.02), such that as TUG decreased, physical function improved 
(i.e. shorter time to complete the task), and estimated VO2 max and number of vigorous 
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bouts of physical activity/week increased.  TUG was not correlated with MET 
hours/week (r < .04).   
Bivariate correlations between the predictor and criterion variables 
Bivariate correlations were conducted for the SF-36 and CDQ with measures of 
physical activity, aerobic fitness, and functional fitness (see Table 23, Table 24, and 
Table 25).  Bivariate correlations were conducted for the SF-36 with the CDQ (see Table 
26 and Table 27).  Bivariate correlations were conducted for the executive function 
variables (Trails A, Trails B, Digits Backwards, Verbal Fluency, CLOX 1, and CLOX 2) 
with the same predictor variables (See Table 28) 
A Bonferroni correction was used for the analysis between predictor variables and 
the HRQL variables.  Sixty correlations were conducted, and thus the p value for 
significance was set at p = .001.  A Bonferroni correction was use for the analysis 
between the predictor variables and the executive function variables.  Twenty-four 
correlations were conducted, and thus the p value for significant was set at p=.002.  There 
were no significant relationships between the predictor variables and criterion (either 
HRQL or executive function) after making the Bonferroni corrections. 
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Table 23 
Correlations for SF-36 Physical subscales and SF-36 PCS aggregate score with 
Predictor Variables 
 
Measure 1 2 3 4 5 6 7 8 
1. Vig Bouts _ _        
2. Met Hours .46** _ _       
3. VO2 max  .19 -.12 _ _      
4. TUG
 a
 -.33* .04 -.59** _ _     
5. SF-36 PF .21 .03 .44** -.37* _ _    
6. SF-36 RP .02 -.11 .17 -.14 .41** _ _   
7. SF-36 BP .17 -.01 .14 .03 .36* .45** _ _  
8. SF-36 GH .23 .07 -.08 -.02 .62** .51** .38** _ _ 
9. SF-36 PCS .23 -.03 .22 -.21 .71** .75** .70** .77** 
Note.  ** significant before a Bonferroni correction at p< .01; * significant before a 
Bonferroni correction at p < .05; 
a
 lower score indicates quicker performance 
 
 
 
Table 24 
Correlations for SF-36 Mental subscales and SF-36 MCS aggregate score with Predictor 
Variables 
 
Measure 1 2 3 4 5 6 7 8 
1. Vig Bouts _ _        
2. Met Hours .46** _ _       
3. VO2 max  .19 -.12 _ _      
4. TUG
 a
 -.33* .036 -.59** _ _     
5. SF-36 VT .13 .15 -.06 -.13 _ _    
6. SF-36 SF .03 -.05 .11 -.07 .21 _ _   
7. SF-36 RE -.02 .02 .13 -.00 .27 .39** _ _  
8. SF-36 MH .05 .09 -.08 .13 .56** .30* .64** _ _ 
9. SF-36 MCS .01 .10 -.09 .08 .65** .52** .77** .89** 
Note.  ** significant before a Bonferroni correction at p< .01; * significant before a 
Bonferroni correction at p < .05; 
a
 lower score indicates quicker performance  
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Table 25 
Correlations for Celiac Disease Questionnaire (CDQ) with the Predictor Variables 
 
Measure 1 2 3 4 5 6 7 8 
1. Vig Bouts _ _        
2. Met Hours .46** _ _       
3. VO2 max  .19 -.12 _ _      
4. TUG
 a
 -.33* .04 -.60** _ _     
5. CDQ Emotion .06 .09 -.00 .03 _ _    
6. CDQ Social .12 .24 -.06 .12 .35* _ _   
7. CDQ Worries .05 -.01 .07 -.12 .42** .38** _ _  
8. CDQ GI .01 -.05 -.10 .13 .34* .51** .44** _ _ 
9. CDQ Total  .08 .08 -.02 .04 .72** .71** .78** .77** 
Note.  ** significant before a Bonferroni correction at p< .01; * significant before a 
Bonferroni correction at p < .05; 
a
 lower score indicates quicker performance  
 
 
 
Table 26 
Correlations for the SF-36 Physical Subscales and SF-36 PCS Aggregate Score with the 
CDQ 
 
Measure 1 2 3 4 5 6 7 8 9 
1. CDQ Emotion _ _         
2. CDQ Social .35* _ _        
3. CDQ Worries .42** .38* _ _       
4. CDQ GI .34* .51** .44** _ _      
5. CDQ Total .72** .71** .78** .77** _ _     
6. SF-36 PF .37* .18 .61** .14 .46** _ _    
7. SF-36 RP .54** .16 .25 .03 .34* .41** _ _   
8. SF-36 BP .32* .44** .32* .37* .48** .36* .45** _ _  
9. SF-36 GH .49** .39** .52** .36* .60** .62** .51** .38** _ _ 
10. SF-36 PCS .37* .28 .45** .20 .45** .71** .75** .70** .77** 
Note.  ** significant before a Bonferroni correction at p< .01; * significant before a 
Bonferroni correction at p < .05 
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Table 27 
Correlations for the SF-36 Mental Subscales and MCS Aggregate Score with the CDQ 
 
Measure 1 2 3 4 5 6 7 8 9 
1. CDQ Emotion _ _         
2. CDQ Social .35* _ _        
3. CDQ Worries .42** .38* _ _       
4. CDQ GI .34* .51** .44** _ _      
5. CDQ Total .72** .71** .78** .77** _ _     
6. SF-36 VT .64** .33* .43** .25 .56** _ _    
7. SF-36 SF .23 .30* .10 .13 .24 .21 _ _   
8. SF-36 RE .69** .30* .35* .36* .56** .27 .39** _ _  
9. SF-36 MH .79** .48** .54** .34* .73** .59** .30* .64** _ _ 
10. SF-36 MCS .78** .46** .41** .37 .68** .65** .52** .77** .89** 
Note.  ** significant before a Bonferroni correction at p< .01; * significant before a 
Bonferroni correction at p < .05 
 
 
 
Table 28 
Correlations for Executive Function with the Predictor Variables 
 
Measure 1 2 3 4 5 6 7 8 9 
1. Vig Bouts _ _         
2. Met Hours .46** _ _        
3. VO2 max  .85 -.12 _ _       
4. TUG
 a
 -.33* .04 -.59** _ _      
5. Trails A
a
 -.06 .04 -.29* .50** _ _     
6. Trails B
a
 -.04 .13 -.25 .39* .76** _ _    
7. Digits -.27 -.09 .23 -.25 -.42** -.38* _ _   
8. Verbal -.28 -.26 .03 -.23 -.33* -.34 .38** _ _  
9.  CLOX 1 -.34* -.01 -.06 .22 -.01 -.24 .08 .13 _ _ 
10. CLOX 2 -.31* -.11 .09 -.00 -.12 -.27 .15 .10 .47* 
Note.  ** significant before a Bonferroni correction at p< .01; * significant before a 
Bonferroni correction at p < .05; 
a
 lower score indicates quicker performance 
 
 
Specific Aim #1 
The canonical correlation (Rc=.23) for the HRQL composite (CDQ total score, 
SF-36 PCS, and SF-36 MCS) with vigorous bouts of physical activity/week was not 
statistically significant.  When MET hours / week was assessed with the HRQL 
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composite, the canonical correlation (Rc=.12) was also not statistically significant.  
Finally, the canonical correlation (Rc=.27) for the HRQL composite with estimated VO2 
max was also not statistically significant.  See Table 29 for a summary of the results.  The 
standardized canonical coefficients for the HRQL composite are in Table 30.  Due to 
non-significant findings for the HRQL variables, the covariates were not assessed. 
 
Table 29 
Specific Aim #1 (HRQL Composite) Results 
 
 
Predictor 
Correlation Significant 
 
 
Vigorous bouts of physical activity/week  
 
Rc=.23 
 
no 
MET hours/week Rc=.12 no 
VO2 max  Rc =.27 no 
 
 
Table 30 
Standardized Canonical Coefficients for the HRQL Composite Variables 
 
Predictor Variable  
 
 
HRQL Composite Variables 
Vigorous 
bouts/week 
MET 
hours/week 
Estimated 
VO2 max 
Timed Up 
and Go 
 
CDQ Total 
 
.009 
 
.458 
 
.291 
 
.472 
PCS -1.026 -.599 -1.031 -1.065 
MCS .179 .661 .373 .225 
Rc .23 .12 .27 .23 
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Specific Aim #2 
The canonical correlation (Rc=.55) for the executive function composite (Trails A, 
Trails B, Digits Backwards, Verbal Fluency, CLOX 1, CLOX 2) with vigorous bouts of 
physical activity/week was statistically significant (p=0.02).  The canonical correlations 
for the executive function composite with MET hours/week (Rc=.32) and estimated VO2 
max (Rc = .36) were not statistically significant.  See Table 31 for a summary of the 
results.  The standardized canonical coefficients for the executive function composite are 
in Table 32.   
 
Table 31 
Specific Aim #2 (Executive Function Composite) Results 
 
 
Predictor 
Correlation Significant 
 
 
Vigorous bouts of physical activity/week  
 
Rc=.55 
 
p=0.02 
MET hours/week Rc=.32 no 
VO2 max  R =.36 no 
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Table 32 
Standardized Canonical Coefficients for the Executive Function Composite Variables 
 
Predictor Variable  
 
Executive Function 
Composite Variables 
Vigorous 
bouts/week 
MET 
hours/week 
Estimated 
VO2 max 
Timed Up 
and Go 
 
Trails A 
 
-.094 
 
.702 
 
-.490 
 
-.621 
Trails B -.538 -.664 -.293 -.237 
Digits Backwards -.459 -.039 .445 .051 
Verbal Fluency -.448 .866 -.323 .158 
CLOX 1 -.480 -.413 -.370 -.527 
CLOX 2 -.375 .352 .259 .093 
Rc .55* .32 .36 .57* 
Note.  * significant canonical correlation (Rc) at p< .05 
 
 
Since vigorous bouts were a significant predictor of the executive function 
composite, covariates were assessed.  Age and diagnosis age were significantly correlated 
with Trails A and Trails B (see Table 33 and Table 34).  Vigorous bouts of physical 
activity/week was still a significant (p=0.024) predictor (Rc=.65, p=0.004) of the 
executive function composite, when the covariates (age and diagnosis age) and vigorous 
bouts of physical activity/week were included in both the canonical correlation and 
multivariate multiple regression models; however, neither age nor diagnosis age were 
significant covariates.  This was due to a high correlation (r= .80, p=.000) between age 
and diagnosis age.  Therefore, diagnosis age was dropped from the model; age and 
vigorous bouts remained.  Age was found to be a significant (p=0.004) predictor 
(Rc=.625, p=0.001) of the executive function composite 
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Table 33 
Bivariate Correlation of the Potential Covariates (Age, Gender, GF Diet Adherence 
Perception, and Diagnosis Type) with the Executive Function Variables 
 
Measure 1 2 3 4 5 6 7 8 9 
1. Trails A
a
 _ _         
2. Tails B
a
 .76** _ _        
3 Digits -.42** -.38** _ _       
4. Verbal -.33* -.34* .38** _ _      
5. CLOX 1 -.01 -.24 .08 .13 _ _     
6. CLOX 2 -.12 -.27 .15 .10 .47** _ _    
7. Age .42** .43** -.27 .17 -.04 -.19 _ _   
8. Gender .04 .07 -.12 .07 .02 -.10 -.07 _ _  
9. GF Diet -.10 .03 .-25 -.17 .24 .05 -.15 -.02 _ _ 
10. Diagnosis -.11 -.12 -.04 .02 -.11 .08 -.18 -.15 .27 
Note.  ** significant before a Bonferroni correction at p< .01; * significant before a 
Bonferroni correction at p < .05; a next to a lower score indicates quicker performance; 
GF Diet = Gluten Free Diet Adherence Perception; Diagnosis = Diagnosis Type 
 
 
Table 34 
Bivariate Correlation of the Potential Covariates (Age at Diagnosis, MMSE, and 
Satisfaction with Information Provided by Diagnosis Doctor) with the Executive Function 
Variables 
 
Measure 1 2 3 4 5 6 7 8 9 10 11 
1 Trails A
a
 _ _           
2Trails B
a
 .76** _ _          
3 Digits -.42** -.38** _ _         
4. Verbal -.33* -.34* .38** _ _        
5. CLOX 1 -.01 -.24 .08 .13 _ _       
6. CLOX 2 -.12 -.27 .15 .10 .47** _ _      
7. DiagAge .34* .34* -.15 .26 .04 -.19 _ _     
8. MMSE -.20 -.09 -.03 .22 .00 -.02 -.21 _ _    
9. DDS-1 .02 .17 .38** .16 -.23 -.08 .06 .19 _ _   
10. DDS-2 .07 -.04 -.12 .08 -.06 -.10 .20 -.18 -.17 _ _  
11. DDS-3 -.16 -.13 -.02 -.15 -.05 .26 -.49** .11 -.22 -.27  
12. DDS-4 -.22 -.21 -.04 .10 .25 -.08 .14 .06 -.21 -.25 -.32* 
 
Note.  ** significant before a Bonferroni correction at p< .01; * significant before a 
Bonferroni correction at p < .05; a next to a lower score indicates quicker performance; 
DiagAge= Age at Diagnosis; DDS = Satisfaction with Information Provided by 
Diagnosis Doctor (dummy variables 1, 2, 3, and 4) 
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Exploratory Aim 
The canonical correlation (Rc=.23) for the HRQL composite (CDQ total score, 
SF-36 PCS, and SF-36 MCS) with TUG was not statistically significant (see Table 35).  
The standardized canonical coefficients for the HRQL composite are in Table 30.  
Covariates were not assessed due to non-significant findings. 
The canonical correlation (Rc=.57) for the executive function composite (Trails A, 
Trails B, Digits Backwards, Verbal Fluency, CLOX 1 CLOX 2) with TUG was 
statistically significant (p=0.01) (see Table 35).  The standardized canonical coefficients 
for the executive function composite are in Table 32.   
 
Table 35 
Exploratory Aim (HRQL Composite) Results 
 
 HRQL Executive Function 
 
Predictor 
 
Correlation 
 
Significant 
 
 
Correlation 
 
Significant 
 
Timed Up and Go (TUG) 
 
Rc=.23 
 
No 
 
Rc=.57 
 
p=0.01 
 
 
 
Since TUG was a significant predictor of the executive function composite, the 
covariates were assessed.  Age and diagnosis age were available for inclusion in the 
model since they were found to be significant with Trails A and Trails B (see Table 33 
and Table 34).  TUG remained a significant (p=0.012) predictor (Rc=.64, p=0.002) of the 
executive function composite, when the covariates (age and diagnosis age) and TUG 
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were included in the both the canonical correlation and multivariate multiple regression 
models; however, neither age or and diagnosis age were significant covariates.  This was 
due to a high correlation (r= .80, p=.000) between age and diagnosis age.  Therefore, 
diagnosis age was dropped from the model; age and TUG remained.  Age was found to 
be a significant (p=.003) predictor (Rc=.62, p=0.00) of the executive function composite, 
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CHAPTER VI 
 
DISCUSSION 
 
The first aim of this study was to identify the degree to which self-reported 
physical activity (MET hours per week; number of bouts of vigorous physical activity) 
and aerobic fitness predicted both HRQL (primary) and executive function (secondary) in 
CD patients, while the second aim was to explore the relationships between functional 
fitness and the same dependent variables.  Forty-seven CD patients completed self-report 
questionnaires, cognitive tests, a functional fitness test, and a submaximal 1-mile walk 
test.  Canonical correlations were used to assess the relationships between the physical 
activity, aerobic fitness, and functional fitness variables with HRQL and executive 
function.  It was hypothesized that higher levels of physical activity, aerobic fitness, and 
functional fitness would be positively predictive of HRQL and executive function.   
Health Related Quality of Life 
The canonical correlations for HRQL with vigorous bouts of physical 
activity/week, MET hours/week, aerobic fitness and functional fitness were not 
significant.  The non-significant results for vigorous bouts of physical activity/week were 
surprising since we had based our hypothesis on both the results of previous literature in 
chronic disease populations and the results of a recent pilot study which used similar 
measures to assess vigorous bouts and HRQL.  Physical activity was assessed in both the 
pilot study and the current study by measuring MET hours/week and number of vigorous 
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bouts of physical activity/week.  Further, this current study assessed HRQL with both the 
SF-36 and the CDQ; the pilot only assessed HRQL with the SF-36.  When physical 
activity is measured, vigorous bouts is usually the most reliable predictor, given that 
participants are more able to accurately recall the number of vigorous bouts of physical 
activity/week performed rather than the details necessary to accurately calculate MET 
hours/week.  Therefore, it was surprising that vigorous bouts of physical activity did not 
predict HRQL.   However, one reason for this nonsignificant finding could be due to the 
fact that HRQL is a gross measurement and therefore, might not be a specific or sensitive 
enough measure in this study.  Yet, it is more likely that the characteristics of the sample 
are driving these results.  For example, the participants in this study scored above the 
mean on both the HRQL and CDQ, indicating, higher levels of HRQL than the normative 
comparison groups.  The positive aspect of this finding is that it suggests that the CD 
patients who volunteered for this study were actually experiencing higher HRQL than 
anticipated.  This sample was mostly recruited from national or local support groups and 
was most likely more active in coping with their disease.  The sample was 72% women, 
which was similar to other research (Ciacci et al., 1995; Green, 2005; Green et al., 2001) 
and the pilot study (Barella et al., 2008), yet the sample, had higher GF diet adherence 
(i.e. all but 4 were at 100% adherence) than other research (Häuser et al., 2007).  In fact, 
this CD sample is also high functioning in other areas, in that they have above average 
participation in both vigorous bouts of activity per week and MET hours, and had been 
on the GF diet for an average of approximately 7 years.  Physical activity has been found 
to help populations who suffer from a chronic disease; however, those with physical 
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limitations from a chronic disease might be impacted more than this CD sample, who 
were not physically limited.  These results indicate that there is not a strong relationship 
between vigorous bouts and HRQL when a high functioning CD sample is used. 
The results for aerobic fitness and HRQL were also somewhat surprising in that 
correlational, cross-sectional and experimental studies that have assessed the relationship 
between aerobic fitness and HRQL in chronic disease populations have mostly shown 
positive relationships.  For example, studies using Fibromyalgia patients (Mannerkorpi et 
al., 2000) and Multiple Sclerosis patients (Sutherland et al., 2001), where aerobic fitness 
was manipulated using an exercise intervention, have supported a positive effect for the 
exercise group with HRQL.  However, changes in aerobic fitness did not always predict 
changes in HRQL.  For example, Rejeski et al. (1996) reported from their review that 
changes in a fitness parameter did not impact HRQL as much as performance based 
measures of dysfunction, while King et al. (1989) found that the change in VO2 max was 
not correlated with any of the other measures in their study except body weight.   
The lack of significant results for functional fitness was also somewhat surprising.  
Functional fitness was an exploratory variable, and we did not have an a priori 
hypothesis; however, since functional status or functional fitness has been found to be 
positively associated with health-related quality of life in past research (Lord & Menz, 
2002; Maly, Costigan, & Olney, 2006; Orfila et al., 2006; Ruhland & Shields, 1997; Sato, 
Kaneda, Wakabayashi, & Nomura, 2007; Wan et al., 1999), we did expect to find a 
positive relationship.   
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The non-significant results for MET hours/week were not surprising.  First, MET 
hours/week was not found to be a positive predictor in our pilot study. Second, it has 
been suggested that MET hours/week is not as readily ascertained as is the number of 
vigorous bouts of physical activity/week (DiPietro et al., 1993).  That is, MET 
hours/week might have more measurement error than vigorous bouts of physical 
activity/week since MET hours/week is comprised of three types of physical activity 
(exercise, household, and gardening) at varying intensities, with some of them also being 
less structured, while vigorous bouts of physical activity/week requires the recall of the 
more intense activities that might be more readily brought to mind (DiPietro et al., 1993; 
Matthews, 2002; Sallis & Saelens, 2000).  
Executive Function 
The canonical correlations for executive function with MET hours/week and 
aerobic fitness were not significant.  However, the canonical correlation for the executive 
function composite with vigorous bouts of physical activity/week and functional fitness 
were statistically significant.  The non-significant results for MET hours/week were not 
surprising for similar reasons as described previously.  That is, MET hours/week was not 
a predictor in our previous pilot study, nor has it been shown to be an accurate predictor 
in past literature due to recall error. 
The results for aerobic fitness were somewhat surprising, in that aerobic fitness, 
usually predicts cognition in correlational studies; however, when tested in experimental 
designs, it has not always been found to be the main mechanism driving changes in 
cognitive function.  Therefore, since our study was correlational in nature, it was 
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hypothesized that aerobic fitness would be a positive predictor of executive function.  For 
example, Etnier et al. (1997) found strong relationships in correlational and cross-
sectional studies (r=.53), while an overall effect size of 0.18 was reported for randomized 
experimental designs.  When correlational studies were examined alone, Etnier et al. 
(2006) reported a smaller positive relationship (r=.29).  However, the results of this 
current study do not provide a positive relationship for exercise and executive function.  
This could be due to the fact that aerobic fitness might not be the main mechanism behind 
changes in cognition.  For example, Colcombe and Kramer (2003) did not find changes in 
VO2 max to significantly alter the effect size found for exercise on executive function.  
Our inability to find a positive relationship between aerobic fitness and executive 
function in this study could be due to the type of aerobic fitness test used; however, we 
don’t believe that to be the case.  The Rockport 1-mile walk estimates VO2 max based on 
mile walk time, gender, heart rate at completion of walk, and age of participant.  All of 
these factors contribute to reliability of the instrument in its prediction of VO2 max, yet, it 
is not flawless in its estimation of VO2 max.  However, Colcombe et al. (2004) tested the 
reliability of the Rockport, by assessing the VO2 max obtained from a maximal bout on a 
treadmill in a sub group of participants, and reported a high correlation with the Rockport 
1-mile walk, thus providing confidence to us about its reliability.  Further, other 
correlational studies have also used sub-max measures of fitness, such as body fat, body 
mass, and lung function (Bunce, 2001; Bunce & Birdi, 1998; Bunce, Warr, & Cochrane, 
1993), pulmonary function measures (Etnier et al., 1999), and a 6-minute walk (Etnier et 
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al., 1999; Lord & Menz, 2002) and were able to find a positive relationship between 
aerobic fitness and cognitive performance. 
The significant results for vigorous bouts of physical activity/week indicate that it 
might be a variable that is an important predictor for a variety of reasons.  First, in studies 
that have assessed physical activity prospectively through self-report measures, they have 
found physical activity to be positively related to cognitive function.  Although, most of 
these studies have not examined relationships for the individual components of physical 
activity (i.e., frequency, duration, intensity), general conclusions drawn from these 
studies are important because they all indicate that something about physical activity 
(type of exercise, kilocalories expended, minutes exercised) is important for cognitive 
function.  For example, most of the prospective studies that have examined cognitive 
performance outcomes support the benefits of physical activity on cognition (Albert et 
al., 1995; Barnes, Yaffe, Satariano, & Tager, 2003; Lytle, Vander Bilt, Pandav, Dodge, & 
Ganguli, 2004; van Gelder et al., 2004).  Further, when clinical outcomes have been 
measured, such as dementia risk (Abbott et al., 2004; Laurin, Verreault, Lindsay, 
MacPherson, & Rockwood, 2001), cognitive function in older women (Lindsay et al., 
2002; Weuve et al., 2004) and Alzheimer’s Disease (AD) (Lindsay et al., 2002; Wilson et 
al., 2002), all but Wilson et al. (2002) showed support for the benefits of physical 
activity.   
From these studies, it has been made clear that physical activity is an important 
predictor of cognition; however, in our current study only vigorous bouts of physical 
activity/week, and not MET hours per/week predicted cognition.  The results from our 
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current study are similar to those Angevaren et al. (2007) who found that average 
intensity of physical activity, and not total time or MET hours of physical activity was 
predictive of cognitive performance in cognitive tasks, such as processing speed, 
memory, mental flexibility, and overall cognition.  Again, participants might be able to 
more accurately recall the number of vigorous bouts of physical activity/week performed 
than the details necessary to accurately calculate MET hours/week (DiPietro et al., 1993; 
Sallis & Saelens, 2000).   
The number of vigorous bouts of physical activity per week is an important 
predictor of executive functioning for a couple of reasons.  First, it has been shown that 
physical activity helps sustain or increase cognitive abilities (Albert et al., 1995; Barnes, 
Yaffe, Satariano, & Tager, 2003; Lautenschlager et al., 2008; Lytle, Vander Bilt, Pandav, 
Dodge, & Ganguli, 2004; van Gelder et al., 2004) and prevents clinical cognitive decline 
or decrease dementia risk (Abbott et al., 2004; Laurin, Verreault, Lindsay, MacPherson, 
& Rockwood, 2001; Lindsay et al., 2002; Podewils et al., 2005; Weuve et al., 2004).   
There are mechanisms, such as, increases in cerebral blood flow, 
neurotransmitters, BDNF, and neural growth that are thought to explain why physical 
activity is beneficial for cognitive performance.  Previous animal research supports the 
link between physical activity and new synapse creation and greater blood flow in the 
cerebral cortex (Black, Isaacs, Anderson, Alcantara, & Greenough, 1990), increased 
expression of BDNF (Klintsova, Dickson, Yoshida, & Greenough, 2004), more synapses 
per neuron and Fos-positive cells (Kleim, Lussnig, Schwarz, Comery, & Greenough, 
1996), and neurogenesis and increased synaptic plasticity (Leal-Galicia, Castaneda-
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Bueno, Quiroz-Baez, & Arias, 2008).  Additionally, human studies support the link 
between physical activity and greater activation in brain regions associated with 
attentional control (Colcombe, Kramer, Erickson et al., 2004).  Therefore, these proposed 
mechanisms in both animal and human studies provide potential reasons for why physical 
activity, and specifically vigorous bouts of physical activity, is related to executive 
function. 
The significant results for the relationship of functional fitness with executive 
function also support the belief that something other than aerobic fitness is responsible 
for the differences in cognitive function found.  The TUG required participants to stand 
quickly from a seated position and walk, jog, or run as quickly as possible to a cone (10 
feet from the chair), turn around and walk back.  This test requires strength in their lower 
extremities (stand up), a quick burst of speed (get to the cone), agility (stop at the cone, or 
turn the cone), and balance (sit back down).  This test might be a more meaningful 
predictor of cognitive performance than aerobic fitness because it takes into account 
multiple measures of fitness (strength, flexibility, anaerobic power).  In addition, the 
instructions, behavior, and functions of this TUG test require executive processes, such as 
planning, decision-making, goal setting, initiating a behavior, self-evaluation, and 
altering the behavior, if needed.  Participants also use other executive functions, such as 
inhibition (to block out distractions), working memory (to update and store the 
directions), and attentional capacity to complete the TUG (Salthouse et al., 2003).  Thus, 
the observed relationship is logical given the need to access executive function resources 
to complete the TUG task.  
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Limitations 
One limitation of this study was that a correlational design was used.  Thus, the 
results of the study do not establish a cause-and-effect relationship between physical 
activity, functional fitness and executive function.  However, this study did provide 
external validity and identification of these relationships and lays the groundwork for 
future studies using an experimental design to test cause-and-effect relationships.  
A second limitation is that random sampling was not used and the study sample 
may not be representative of the general population of CD patients.  That is, our CD 
sample had better HRQL when compared to the normative groups, and is likely a very 
high functioning sample of CD patients. 
A third limitation was the use of the canonical correlations for the statistical 
analyses.  The canonical correlation analysis was determined to be the best statistical tool 
for this data, given that there was an interest in determining the relationships between 
individual predictor variables and sets of dependent variables.  Multiple regression could 
have been chosen if there was a many-to-one relationship (many predictors to one 
dependent), but the hypotheses that were developed a priori led us to choose a statistical 
analysis tool that would analyze and determine a one-to-many relationship.  That is, we 
were interested in determining the relationship of each of our predictor variables with 
HRQL and Executive Function.  Since this was the first study to assess these 
relationships, hypotheses were developed around the larger constructs, HRQL and 
Executive Function, and predictions were not made about individual subscales or tests.  
HRQL consisted of both the SF-36 measure, as well as the CDQ, giving us a total of 15 
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variables.  Executive function consisted of six main variables.  Therefore, this canonical 
correlation analysis allowed variates or composites of both HRQL and Executive 
function to be created and correlated with each of the predictors.  However, as previously 
described, when a canonical correlation is used, it is not possible to identify the specific 
individual relationships.  Thus, the use of this analysis is limiting in that it makes it 
difficult to determine the importance of each variable that composed the composite, as 
well as to draw conclusions about the overall direction of the relationships that were 
found.  Therefore, future studies will need to consider the limitations of using a canonical 
analysis.   
Future Direction 
 CD impacts 1 in 131 people in the United States and is associated with lower 
levels of HRQL and cognitive functioning.  Physical activity and aerobic fitness have 
been found to positively predict HRQL and cognition, yet those relationships had not 
been investigated in CD patients.  Therefore, this study has made an important 
contribution to the literature by investigating these relationships in this population.  This 
study found that number of vigorous bouts of physical activity/week and functional 
fitness were statistically significant positive predictors of the executive function 
composite.  These findings are important for a couple of reasons.  First, this is the first 
study to show established positive relationships between physical activity and executive 
function in CD patients.  Second, this study provides preliminary support for these 
positive relationships and suggests the need to use interventions to determine the 
potential causal relationship between physical activity and executive function.  Third, to 
 124 
determine if aerobic fitness is an important variable of interest, it will be important to not 
only measure aerobic fitness at one time point, but to also assess how changes in aerobic 
fitness impact HRQL and executive function.  Future research may also want to use 
similar executive function tests; however, the CLOX test and the MMSE are not 
recommended, unless the subject sample is known to have dementia or severe cognitive 
impairment.  This recommendation stems from a limited range of responses on both tests, 
indicating both high and homogeneous scores.  This problem could also be solved by 
including a more representative sample of CD patients.  This representative sample may 
provide a larger range of scores on the cognitive tests mentioned above, and also on the 
HRQL measures, since our current sample had scores better than the norms for most of 
the outcome measures. 
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APPENDIX 
APPENDIX A: CONSENT FORM 
Consent to Act as a Human Participant: Long Form 
UNIVERSITY OF NORTH CAROLINA AT GREENSBORO 
 
THIS IS A TEMPLATE FOR THE LONG FORM FOR OBTAINING INFORMED CONSENT FOR 
PARTICIPATION IN RESEARCH. IT MUST BE ADAPTED TO INCLUDE ALL OF THE 
INFORMATION REQUIRED FOR INFORMED CONSENT. IF AN ITEM IS NOT APPROPRIATE FOR 
THE STUDY, PLEASE DELETE IT FROM THE FORM. 
 
CONSENT TO ACT AS A HUMAN PARTICIPANT: LONG FORM 
 
Project Title:  The influence of physical activity and aerobic fitness on health-related quality of life (HRQL) 
and cognitive performance in Celiac Disease (CD) patients. 
 
Project Director:  Lisa A. Barella 
 
Participant's Name: ____________________________________ 
 
DESCRIPTION AND EXPLANATION OF PURPOSE AND PROCEDURES: 
 
Lisa A. Barella, a doctoral student in the Exercise and Sport Science Department, has requested your 
participation in a research study at this institution. The title of the research is The influence of physical 
activity and aerobic fitness on HRQL and cognitive performance in CD patients. 
 
The purpose of the research is to identify the degree to which physical activity status and aerobic fitness are 
related to HRQL and cognitive performance in CD patients. 
 
You will be asked to provide your informed consent to participate.  You will be asked to fill out several 
questionnaires and to perform cognitive testing, a functional fitness test, and an aerobic fitness test.  The 
aerobic fitness test and the functional fitness test will be conducted either inside or outside.  During the 
functional fitness test, you will be asked to rise from a chair with arm rests, walk 3 meters, turn 180 
degrees, return to the chair, and sit down.  During the aerobic fitness test, you will be asked to walk as fast 
as you can for one mile or until you ask for the test to stop.  After completion of the aerobic fitness test you 
can walk to cool down for approximately 5 minutes.  The testing will be done following the guidelines of 
the American College of Sports Medicine. The amount of time required is approximately two hours per 
testing session. 
 
There are no feasible alternative procedures available for this study. 
 
You are free to refuse to participate or to withdraw your consent to participate in this research at any time 
without penalty or prejudice.  Your participation is entirely voluntary.  You are also encouraged to ask 
questions at any time. 
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RISKS AND DISCOMFORTS: 
There are minor risks that are possible as a result of participating in this study.  These include muscle fatigue 
and dizziness during and after the exercise, abnormal changes in heart function, and, in very rare instances, 
heart attack (non-fatal or fatal) may also occur during the exercise test. However, the American College of 
Sports Medicine (2006) has provided the following information regarding this risk:  The incidence of sudden 
cardiac death during vigorous exertion in healthy adults is estimated at one death per year for every 15,000 to 
18,000 individuals.  The overall risk of exercise testing in a mixed subject population is approximately six 
cardiac events (e.g. heart attack, dangerous irregular heartbeat, or death) per 10,000 tests.  These are all 
conditions that would require immediate medical attention.  In the unlikely event of an emergency, the 
experimenter will provide Cardio-Pulmonary Resuscitation (CPR) and/or administer an Automatic External 
Defibrillator (AED) if appropriate and will call 911 for emergency assistance. 
 
POTENTIAL BENEFITS: 
The direct benefit that you will receive from this study is that you will be informed of your estimated 
aerobic fitness level.  The indirect benefits are that this research will help the researchers gain an 
understanding of the relationship between physical activity, aerobic fitness, and the dependent variables 
(HRQL and cognitive performance).  The results of the research study may be published but your name 
will not be revealed. In order to maintain confidentiality, the investigators (Dr. Etnier and Lisa A Barella) 
will substitute your name with a code number.  Data will be stored in a locked office in the Exercise and Sport 
Psychology Lab in the Health and Human Performance Building at the University of North Carolina at 
Greensboro.  Data will be destroyed via shredding after publication (anticipated to be 2011).  Electronic data 
relevant to this study may be stored indefinitely, but will be free of personal identifiers. 
 
There is no compensation for participation in this study; however, upon completion of the study, a small 
donation will be made to the Gluten Intolerance Group in your name, or anonymously, if that is your 
preference. 
 
COMPENSATION/TREATMENT FOR INJURY: 
There is no compensation for any physical or psychological events that may result from your participation.  
Please contact Mr. Eric Allen at (336) 256-1482 if you sustain any research-related injuries.    
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CONSENT:   
By signing this consent form, you agree that you understand the procedures and any risks and benefits 
involved in this research.  You are free to refuse to participate or to withdraw your consent to participate in 
this research at any time without penalty or prejudice; your participation is entirely voluntary.  Your 
privacy will be protected because you will not be identified by name as a participant in this project. 
 
The University of North Carolina at Greensboro Institutional Review Board has approved the research and 
this consent form.  The University of North Carolina at Greensboro Institutional Review Board insures that 
research which involves people follows federal regulations.  Questions regarding your rights as a 
participant in this project can be answered by calling Mr. Eric Allen at (336) 256-1482.  Questions 
regarding the research itself will be answered by Lisa Barella by calling (336) 253-5539.   Any new 
information that develops during the project will be provided to you if the information might affect your 
willingness to continue participation in the project.  You will be offered a copy of this consent form. 
 
By signing this form, you are affirming that you are 18 years of age or older and are agreeing to participate 
in the project described to you by Dr. Jennifer Etnier or Lisa A. Barella. 
 
____________________________________   ______________ 
Participant's Signature      Date  
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APPENDIX B: GENERAL DEMOGRAPHIC AND HEALTH STATUS 
QUESTIONAIRE 
 
General Demographic and Health Status Questionnaire 
 
 
Date: __ __/__ __/__ __ __ __   Identification Number: __ __ __ __ __ 
 
General Demographic and Health Status Questionnaire 
 
Directions: This questionnaire asks about demographic information, along with your current and past 
health status.  Please answer as accurately as possible.  Please check “X” in the correct   or write in a 
specific answer when asked.   
 
1). Gender 
  Male    Female 
 
2). Date of Birth: __ __/__ __/__ __ __ __ Age (in years) ________ 
 
3). Marital Status:  
   Single   Married/Partnered   Separated   Divorced   Widowed      
 
4). Highest Level of School Completed: 
  Grade School 
  High School 
  2-year Technical School/2-year Associate Degree 
  Bachelor’s Degree 
  Masters Degree 
  Doctoral (PhD/PsyD/MD/EdD) 
 
5). Do you have Celiac Disease? 
 
  NO   YES 
 
a). If, NO, stop completing this questionnaire 
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Identification Number: __ __ __ __ __ 
 
6). Were you diagnosed with Celiac Disease with a Biopsy? 
 
  NO   YES 
 
  a). If, NO, How were you diagnosed? ______________________________ 
 
 
7). What was the date of your diagnosis? __ __/__ __/__ __ __ __  
 
 
8). Are you currently (within the past 2 weeks) adhering to a gluten free diet? 
 
  NO   YES 
 
(If, NO, proceed to Q#9) 
(If, YES, skip Qs#9, 10 and 11; proceed to Q#12) 
 
------------QUESTIONS FOR THOSE WHO ARE NOT ADHEREING TO A GLUTEN-FREE DIET-------
------ 
 
9).  If, NO to question #8, why are you NOT adhering to the gluten free diet? ____________ 
 
 
 
10).  If, NO to question #8, did you adhere to the gluten free diet in the past? 
 
  NO   YES 
 
  a). If YES, when did you start the gluten free diet? __ __/__ __/__ __ __ __ and when 
did you end the gluten free diet? __ __/__ __/__ __ __ __ 
 
  b). If NO to question #10, skip Q#11; proceed to Q#14 
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Identification Number: __ __ __ __ __ 
 
11). When you were adhering to the gluten free diet in the past, how would you rate your adherence? 
 
  All of the time, 100% adherence; I never intentionally ate anything with gluten; I checked all 
foods very carefully 
  Almost all of the time, 90% adherence; I rarely ever ate anything with gluten, but about 10% of 
the time I would consume foods with gluten 
  Most of the time, 75% adherence; I usually ate gluten free; Occasionally, I allowed myself to 
consume foods with gluten.  This occurred about 25% of the time 
  Some of the time, 50% Adherence; I ate gluten free foods 50% of the time; however, during the 
other 50%, I ate foods with gluten 
  A little of the time, 25% Adherence; I ate foods with gluten mostly; Once in awhile, I tried to eat 
gluten free foods 
  None of the time, 0% Adherence: I never ate gluten free foods 
 
Now, SKIP to Question #14 
 
-------------QUESTIONS FOR THOSE WHO ARE ADHEREING TO A GLUTEN-FREE DIET-------------
-- 
        
12). When did you start adhering to the gluten free diet? 
 
 Date: __ __/__ __/__ __ __ __  
 
13). How would you rate your current (within the past 2 weeks) adherence to the gluten free diet? 
  All of the time, 100% adherence; I never intentionally eat anything with gluten; I check all foods 
very carefully 
  Almost all of the time, 90% adherence; I rarely ever eat anything with gluten, but about 10% of 
the time I consume foods with gluten 
  Most of the time, 75% adherence; I usually eat gluten free; I occasionally allowed myself to 
consume foods with gluten about 25% of the time 
  Some of the time, 50% Adherence; I eat gluten free foods 50% of the time; during the other 
50%, I eat foods with gluten 
  A little of the time, 25% Adherence; I eat foods with gluten mostly; Once in awhile, I try to eat 
gluten free foods 
  None of the time, 0% Adherence: I never eat gluten free foods 
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14).  Please rate how helpful your doctor was in explaining Celiac Disease to you when you were 
diagnosed? 
 
 
Not at all Slightly Moderately Quite a bit Extremely 
1 2 3 4 5 
 
15). Do you currently see a medical doctor for Celiac Disease related issues? 
 
  NO   YES 
 
  a). If NO, go to question #16 
 
b). If YES, how would you currently rate your doctor’s communication with you? 
 
 
  
Poor Fair Good Very good Excellent 
1 2 3 4 5 
 
 
16). Were you referred to a nutritionist upon being diagnosed with Celiac Disease? 
 
  NO   YES 
  
 a). If NO, go to question #19 
 
b). If YES, did you have an appointment or consultation with the nutritionist? 
   
NO YES 
  
 a). If NO, go to question #19 
  
 b). If YES, please answer questions  #17 + #18 
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Identification Number: __ __ __ __ __ 
 
17). How satisfied were you with the services that the nutritionist offered with regards to the Gluten Free 
Diet? 
 
 
Not at all Slightly Moderately Quite a bit Extremely 
1 2 3 4 5 
 
 
18). Were there any specific areas that you were dissatisfied with when consulting with the nutritionist? 
 
  NO   YES 
  
a). If YES, please list: ___________________________________________ 
 
______________________________________________________________ 
  
 
19). What physical/bodily symptoms did you experience prior to your diagnosis with Celiac’s Disease?   
 
___________________________________________________________________________ 
 
___________________________________________________________________________ 
 
20). What mental or cognitive symptoms did you experience prior to your diagnosis with Celiac Disease?  
 
___________________________________________________________________________ 
 
___________________________________________________________________________ 
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Identification Number: __ __ __ __ __ 
 
21). If you adhere to the gluten free diet (either currently or in the past), did the diet help relieve any of 
your previous symptoms? 
 
  NO   YES 
 
If YES, what symptoms were alleviated? ____________________________ 
 
______________________________________________________________ 
   
If NO, what symptoms were still present after being on the gluten free diet for at least 6 
months? 
 
  List Symptoms: ________________________________________ 
 
________________________________________________________ 
 
  This Question is Not Applicable; I was never on the gluten free diet for 6 
months or MORE 
 
22). Other than Celiac Disease, do you have any other autoimmune diseases? 
 
  NO   YES 
 
  If, YES, please list: __________________________________________ 
 
_____________________________________________________________________ 
 
23). Other than Celiac Disease do you have any other diseases (anemia, osteoporosis, thyroid)? 
 
  NO   YES 
 
  If, YES, please list: _________________________________________ 
 
_____________________________________________________________________ 
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24). Do you have any other medical complaints, problems, or disorders? 
 
  NO   YES 
 
  If, YES, Please list: ______________________________________________ 
 
___________________________________________________________________________ 
 
25). Are you currently taking any medications? 
 
  NO   YES 
 
 If, YES, please list: ______________________________________________ 
 
___________________________________________________________________________ 
 
26). Are you currently (within the past 2 weeks) physically active? 
 
  NO   YES 
 
  If, YES, please list type of activity: ____________________ 
  
If, YES, please list the typical number of sessions per week of the activity: __ 
 
If, YES, please list the typical duration of the activity: ___________(minutes) 
 
(Note: if you participate in MORE than ONE activity, please feel free to list the OTHER activities in the 
remaining space below and use more space on the back of this sheet if necessary) 
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Activity #2 
 
If, YES, please list type of activity: ____________________ 
  
If, YES, please list the typical number of sessions per week of the activity: ________ 
  
If, YES, please list the typical duration of the activity: ________________ (minutes) 
 
  
Activity #3 
  
If, YES, please list type of activity: ____________________ 
  
If, YES, please list the typical number of sessions per week of the activity: ________ 
  
If, YES, please list the typical duration of the activity: ________________ (minutes) 
 
27). Are you interested in being contacted about the results of this study?  (Upon receipt by the 
investigators, this information will be stored separately from the questionnaire responses and will not be 
tied to your data). 
 
NO  YES 
 
 If YES, what is your name: __________________________________ 
 
If, YES, please list your telephone number: _____________________ 
  
 If YES, please list your email (if you have one): _________________ 
 
21). Is there anything else that you would like to mention? ___________________________ 
 
___________________________________________________________________________ 
 
Thank you for completing the survey!  We really appreciate your help!   
 
For UNCG Use Only:  Certification ID of person entering this form: __ __ __ __ ___  
Date Entered: __ __/__ __/__ __ __ __ 
 
